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iZusammenfassung
Die vorliegende Arbeit befasst sich mit multiplen Kontrasttests für Mittelwerte nor-
malverteilter Daten. Diese haben im Vergleich zu anderen Methoden den Vorteil,
dass i) Testaussagen für jeden Einzelvergleich möglich sind, ii) deren Korrelatio-
nen berücksichtigt werden, iii) dadurch der Gesamtfehler erster Art eingehalten und
ausgeschöpft wird, und iv) sich für jeden Einzelvergleich simultane Konfidenzinter-
valle ableiten lassen. Dies wird erreicht durch die Verwendung einer gemeinsamen
multivariaten t-Verteilung aller zu betrachtenden Vergleiche. Darüber hinaus sind
multiple Kontrasttests sowohl für Differenzen als auch für Verhältnisse von Mittel-
werten formulierbar. Neben der Normalverteilung ist Varianzhomogenität der Daten
allerdings eine weitere Annahme. Zudem sind multiple Kontrasttests beschränkt auf
eine zu betrachtende Messgröße (Endpunkt).
Ziel dieser Dissertation ist es zum einen, multiple Kontrasttests für die Anwendung
auf varianzheterogene Daten zu erweitern. Hierfür werden drei mögliche Proze-
duren vorgestellt und im Hinblick auf die Einhaltung des Gesamtfehlers erster Art
verglichen. Ziel ist es weiterhin, multiple Kontrasttests für die simultane Analyse
mehrerer Endpunkte zu verallgemeinern. Beide Teilprobleme erfordern die Her-
leitung entsprechender approximativer multivariater t-Verteilungen. Simulations-
studien zeigen, dass für beide Ansätze der Gesamtfehler erster Art eingehalten wer-
den kann. Die Auswertung von Realdatenbeispielen verdeutlicht die Notwendigkeit
der Verfahren und dient ihrer Veranschaulichung.
Schlagworte: multiple Kontrasttests, Heteroskedastizität, multiple Endpunkte
ii
Abstract
This research considers multiple contrast tests for means of normally distributed
data. Their advantages, as compared to other methods, are that i) test decisions
are available for all individual comparisons, ii) correlations are taken into account,
iii) the familywise error type I is maintained and exploited for that reason, and iv)
simultaneous confidence intervals can be derived. Therefore, a joint multivariate
t-distribution of all comparisons is used. Moreover, multiple contrast tests can be
formulated for both differences and ratios of means. Besides following a normal dis-
tribution, the data are also assumed to have homogeneous variances. Furthermore,
multiple contrast tests are restricted to one single endpoint.
The aim of this dissertation is to facilitate multiple contrast tests in the presence of
heteroscedasticity. Three candidate procedures are introduced and compared with
regard to their ability to maintain the familywise error type I. On the other hand, an
extension for the case of multiple endpoints is investigated. For both tasks, approx-
imate multivariate t-distributions are derived. Simulation studies show that both
approaches control the familywise error type I. Real data examples are analyzed in
order to demonstrate the necessity of the methods, and to illustrate them.
Keywords: multiple contrast tests, heteroscedasticity, multiple endpoints
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Chapter 1
General Introduction
Usually, multiple comparison procedures (MCPs) for means of normally distributed
populations can be evaluated as multiple contrast tests (MCTs) or by related simul-
taneous confidence intervals (SCIs). Several contrasts, representing linear functions
of these means, are estimated and typically tested for deviation from zero. Be-
cause correlations between the contrasts are involved in a joint distribution, MCTs
exactly maintain the familywise error rate (FWE) over all contrasts. No further
multiplicity-adjustment is needed. The all-pair comparison of Tukey [1953] and the
many-to-one comparison of Dunnett [1955] are well-known examples. Bretz [2006]
has formulated the trend test of Williams [1971] as an approximate MCT. Also, the
user is free to create other interesting problem-specific contrasts. Moreover, Dilba
et al. [2004] have dealt with MCTs and SCIs for ratios of means. If relative changes
(e.g., in per cent) are of more interest than absolute ones, this approach is suitable.
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All the resulting MCTs and SCIs assume homogeneous variances as a general rule.
This fact is often attributed to an easier derivation and to mathematical convenience,
but it is not always realistic. For example, dose finding studies can have the problem
of heteroscedasticity because the data’s variance depends on the dose effect (see the
data in Westfall [1997]). It is common to apply these procedures without checking
the validity of this assumption. If no information about the data is available (e.g.
from preliminary tests) before statistical analysis, it is not advisable to presume
homogeneous variances. Existing effects or negligible differences may be under- or
overestimated, respectively, leading to wrong decisions.
Furthermore, MCTs are restricted to data with a single outcome (endpoint). How-
ever, measurements for multiple endpoints frequently appear in experiments (see
the data in Schulte et al. [2002]). The number of endpoints must then be taken
into account too, for the FWE. Their correlations are also important because, e.g.,
highly correlated endpoints do not contain the same amount of information about
the data as uncorrelated ones.
The outline of this work is as follows. In Chapter 2, basic underlying concepts
and distributions are recalled and investigated. Chapter 3 describes and compares
adequate approaches to handle the problem of heteroscedasticity, while Chapter 4
deals with an extension for multiple endpoints. Conclusions and a discussion are
given in Chapter 5.
Chapter 2
Statistical Concepts and
Distributions
Before turning to the main parts of this work, some important underlying concepts
and distributions, which build a base of the following methodology, are recalled and
investigated.
2.1 Some Basic Concepts
Multiple testing problems first of all raise the question how to construct suitable
hypotheses. There are two basic approaches. The intersection-union method of test
construction may be useful if the null hypothesis can be conveniently expressed as
3
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a union, that is,
H0 =
k⋃
i=1
H0i.
Suppose that a suitable test is available for each H0i : θ ∈ Θi versus H1i : θ ∈ Θci .
We can then write
H0 : θ ∈
k⋃
i=1
Θi.
Say the rejection region for the test of H0i is {x : Ti(x) ∈ Ri}. Then, the rejection
region for the intersection-union test (IUT) of H0 is
k⋂
i=1
{x : Ti(x) ∈ Ri}.
This means that the global null hypothesis H0 is rejected if and only if each of its
component (local null) hypotheses H0i is rejected. Depending on the test direction,
let the local rejection region for each of the individual tests be {x : Ti(x) > c} with
a common c for all these tests. The global rejection region of the IUT is therefore
k⋂
i=1
{x : Ti(x) > c} = {x : min
i=1,...,k
Ti(x) > c}.
Thus, the test statistic for testing H0 is
T (x) = min
i=1,...,k
Ti(x).
Information about the IUT’s size is given by the following
Theorem 2.1.1. Let αi be the size of the test of H0i with rejection region Ri (i =
1, . . . , k). Then the IUT with rejection region R =
⋂k
i=1Ri is a level-α test, that is,
its size is at most α with
α = max
i=1,...,k
αi.
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Some simple but typical examples for IUT are as follows.
Example 2.1.1. The TOST concept can be used to test the equivalence of two
groups by performing two one-sided tests. The first test is used to ensure that the
groups do not differ by more than a specified positive amount (e.g., δ); the second one
is to ensure that they do not differ by more than a specified negative amount (e.g.,
−δ). Only if both can be shown, equivalence can be stated. The null hypothesis can
be expressed as a union of two partial hypotheses. Both can be tested at level α.
Example 2.1.2. If two groups with multiple endpoints have to be compared, the
aim may be to show non-inferiority (or superiority) of the first over the second group
for all endpoints. For example, when testing for side effects, safety is only declared
when all endpoints are safe. That is to say, the first group (new compound) is
safe only if it is non-inferior to the second group (control) for all endpoints. Each
endpoint is then related to a partial hypothesis; the overall null hypothesis is the
union of them. All the endpoints can be tested at level α.
In addition to the intersection-union method of test construction there is the union-
intersection method. It is useful if the null hypothesis can be conveniently expressed
as an intersection, i.e.,
H0 =
k⋂
i=1
H0i.
Supposing again that a suitable test is available for each H0i : θ ∈ Θi versus H1i :
θ ∈ Θci , we can write
H0 : θ ∈
k⋂
i=1
Θi.
The rejection region for the test of H0i is then {x : Ti(x) ∈ Ri}. Hence, the rejection
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region for the union-intersection test (UIT) of H0 is
k⋃
i=1
{x : Ti(x) ∈ Ri}.
The global null hypothesis H0 is thus rejected if and only if at least one of its
component (local null) hypotheses H0i is rejected. Suppose the test direction for
which the local rejection region for each of the individual tests is {x : Ti(x) > c}
with a common c for all these tests. Then, the global rejection region of the UIT is
k⋃
i=1
{x : Ti(x) > c} = {x : max
i=1,...,k
Ti(x) > c},
so that the test statistic for testing H0 is
T (x) = max
i=1,...,k
Ti(x).
Examples for UITs are as follows.
Example 2.1.3. Two-sided testing is used if the aim is to show a difference between
two groups, regardless of the algebraic signs of this difference. Formally, two tests
are performed with opposite test direction. The first serves to show whether the
groups differ by a positive amount; the second one is to show whether they differ
by a negative amount. If at least one case can be shown, a significant difference can
be stated. The null hypothesis can be expressed as an intersection of two partial
hypotheses. Both must be tested at level α/2.
Example 2.1.4. The Dunnett procedure [Dunnett, 1955] compares several groups
with one control. The null hypothesis is an intersection of partial hypotheses, one for
each non-control group. To maintain the error type I for the overall null hypothesis
at level α, a multivariate t-distribution is used that takes the number and correlations
of the involved comparisons into account.
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Example 2.1.5. If two groups with multiple endpoints have to be compared, the
aim may be to show for which endpoints they differ. For example, when testing
for side effects, the first group (new compound) is declared hazardous if at least
one endpoint is hazardous as compared to the second group (control). Then each
endpoint is related to a partial hypothesis and the overall null hypothesis is the
intersection of them. All endpoints must be tested at level α/k, where k is the
number of endpoints.
These and further considerations about IUT and UIT may be found in Casella and
Berger [2002]. Of course, testing problems can also be mixtures between IUTs and
UITs; see Bofinger and Bofinger [1995] and Quan et al. [2001] for example. The
testing problems in the following chapters will turn out to be UITs. We therefore
recall some definitions and theorems related to these test procedures. They may
also be found in Hochberg and Tamhane [1987] and Gabriel [1969], together with
the related proofs which are omitted here for brevity. The IUT was mentioned here
for reasons of completeness and is not considered below.
A hypothesis H(s)0 is said to imply H
(r)
0 when the parameter values postulated by
H
(s)
0 form a subset of the parameter values postulated by H
(r)
0 . A family of hy-
potheses is said to be hierarchical if an implication relation holds between at least
two hypotheses. If a hypothesis H(s)0 implies H
(r)
0 , then H
(r)
0 is called a component
of H(s)0 , according to Gabriel [1969]. A hypothesis with no components is called
minimal ; all other hypotheses are called non-minimal [Gabriel, 1969]. An MCP is
called coherent, if the following property holds: If H(s)0 is not rejected, then H
(r)
0 is
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also not rejected for any pair of hypotheses (H(r)0 , H
(s)
0 ) such that H
(s)
0 implies H
(r)
0 .
This requirement has been introduced by Gabriel [1969] and earlier by Lehmann
[1957] as compatibility. A coherent MCP that rejects a hypothesis also rejects all
hypotheses implying it. For a hierarchical family of hypotheses, consonance refers
to the property that whenever any non-minimal hypothesis is rejected, at least one
of its components is also rejected (see Gabriel [1969]). An MCP with this property
is called consonant. A simultaneous test procedure for a hierarchical family of hy-
potheses is characterized by a collection of test statistics Zs, s ∈ I, and a common
critical constant c such that the procedure rejects H(s)0 if Zs ≥ c, s ∈ I. The test
statistics Zs are said to be monotone if Zs ≥ Zr with probability one whenever H(s)0
implies H(r)0 . The above UIT is such a simultaneous test procedure because it com-
pares each Ti with the same quantile c and Zs can be defined as maxi=1,...,s Ti and
I = {1, . . . , k}. The following theorems clarify the need for the above definitions
and connects them.
Theorem 2.1.2. The simultaneous test procedure stated above is coherent for any
choice of the critical constant c if and only if the test statistics Zi are monotone.
Theorem 2.1.3. For a hierarchical family of hypotheses, a single-step test procedure
is coherent and consonant if and only if it is a UIT.
Theorem 2.1.4. The above UIT is a level-α test if c is chosen to be the upper α
quantile of the distribution of maxs∈I Zs.
Furthermore, it can be shown that associated confidence sets have level (1 − α).
In summary: If a test procedure is known to be a UIT, constructed in the above
manner, it is coherent and consonant; the proper choice of a quantile c guaranties a
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level-α test.
2.2 Multivariate Normal and t-distribution
The multivariate normal distribution plays a dominant role in both the historical
and actual development of statistical theory. Indeed, even its name points up its
central meaning. Its application areas are various. A comprehensive and coherent
treatment of classical and new results related to the multivariate normal distribution
is provided by Tong [1990], for example.
A random vector X = (X1, ..., Xk)′ is said to have a k-variate normal distribution
with mean vector µ ∈ Rk and covariance matrix Σ ∈ Rk×k if its characteristic
function ψX(u) = E(eiu
′X) is given by
ψX(u) = exp(iu
′µ− 1
2
u′Σu) (u ∈ R)
where i is the imaginary unit. We write X ∼ Nk(µ,Σ). If Σ is positive definite,
then the density function of X exists and is given by
φ(x) =
1
(2pi)
k
2 |Σ| 12
e−
1
2
(x−µ)′Σ−1(x−µ) (x ∈ Rk).
In this case we say thatX has a nonsingular distribution. If the Xi (i = 1, ..., k) are
standardized so that E(Xi) = 0 and V ar(Xi) = 1, then Σ is a correlation matrix
denoted by R = (ρij)i,j with off-diagonal elements ρij = corr(Xi, Xj) for i 6= j and
we write X ∼ Nk(µ,R).
The multivariate t-distribution is of increasing importance in statistical modeling.
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It has been found useful in inference problems concerning the mean vector of a
multivariate normal distribution. A large number of modifications and extensions
of the standard multivariate t-distribution has been proposed in the literature. A
comprehensive review is given by Nadarajah and Dey [2005]. For a more detailed
account, see Kotz and Nadarajah [2004]. The following and further considerations
may also be found in Tong [1990] or in Hochberg and Tamhane [1987] p.365 ff,
together with the related proofs which are omitted here for brevity.
Let X = (X1, ..., Xk)′ ∼ Nk(µ,R), let U be a χ2ν random variable which is dis-
tributed independently of X and denote
Ti =
Xi√
U/ν
(i = 1, . . . , k). (2.1)
For µ = 0 the distribution of T = (T1, ..., Tk)′ is called a central k-variate t-
distribution with ν degrees of freedom and associated correlation matrix R and we
write T ∼ tk(ν,R). Otherwise (2.1) is called a non-central k-variate t-distribution
with non-centrality parameter µ, and is denoted by T ∼ tk,µ(ν,R). If R is positive
definite, then the density function of T exists and is given by
gk(t; ν,R) =
Γ(1
2
(ν + k))
(piν)
k
2 Γ(ν
2
)|R| 12
(
1 +
1
ν
t′R−1t
)− 1
2
(ν+k)
(t ∈ Rk). (2.2)
Important characteristics are given by the following
Lemma 2.2.1. Let T ∼ tk(ν,R). Then for ν > 2:
E(Ti) = 0 (i = 1, . . . , k),
V ar(Ti) =
ν
ν − 2 (i = 1, . . . , k),
Cov(Ti, Tj) =
νρij
ν − 2 (i, j = 1, . . . , k).
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This result ensures that the matrix R in (2.2) is the correlation matrix of T . Fur-
thermore, note that the multivariate t-distribution belongs to the class of elliptically
countered distributions. It is ellipsoidally symmetric about µ (see Tong [1990]). The
next lemma delimits the possible correlations, e.g., for simulating random numbers.
Lemma 2.2.2. Let there be random variables T ∼ tk,µ(ν,R) or X ∼ Nk(µ,R),
and let the elements of R be ρij = ρ for all i 6= j = 1, . . . , k. Then the smallest valid
value ρmin for ρ depends on the dimension k according to
ρmin = − 1
k − 1 . (2.3)
Proof. A condition for the density function of T orX to exist is that the correlation
matrix R is positive definite (positive semidefinite). Hence, each principal minor of
R has to be positive (non-negative). Complete induction with respect to k leads to
(2.3).
To give an example, Figure 2.1 illustrates the behavior of a random variable T ∼
t3(20,R) depending on its correlation structure. Here, all the variable’s components
are equicorrelated, ρij = ρ for all i, j = 1, . . . , k, i 6= j. The red points representing
realizations of T for the case of maximal negative correlation ρ = −1
2
lie exactly
on a disk. The green points having correlation ρ = 0 form a ball, while the blue
points have maximal positive correlation, i.e., ρ = 1. They are located on a line
which is orthogonal to the disk of the red points. A general conclusion is given by
the following
Corollary. The realizations of the k-variate random variables T ∼ tk,µ(ν,R) or
X ∼ Nk(µ,R) with maximal negative correlation ρ = − 1k−1 form a (k − 1)-
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Figure 2.1: Trivariate t-distributed random variable with ν = 20 and maximal nega-
tive correlation (red), correlation 0 (green), and maximal positive correlation (blue).
dimensional subspace of Rk, for correlation ρ = 0 a k-dimensional ball, and for
maximal positive correlation ρ = 1 a line that is orthogonal to the subspace obtained
by maximal negative correlations.
A relationship between multivariate t- and normal distribution is considered by
Lemma 2.2.3. Let gk(t; ν,R) and fk(x; 0,R) be the density functions of the random
variables T ∼ tk(ν,R) and X ∼ Nk(0,R), respectively. Then
lim
ν→∞
gk(t; ν,R) = fk(t; 0,R) ∀t ∈ Rk.
Corollary. With T ∼ tk(ν,R) and X ∼ Nk(0,R), define the equicoordi-
nate quantiles cν,α and cα for α ∈ (0, 1) as P
(⋂k
i=1{Ti ≤ cν,α}
)
= α and
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P
(⋂k
i=1{Xi ≤ cα}
)
= α. Then
lim
ν→∞
cν,α = cα.
A practical consequence of Lemma 2.2.3 and its corollary for test decisions is hence
that the use of quantiles of a multivariate normal distribution instead of those of a
t-distribution may be an acceptable approximation in the case of large sample sizes.
However, this leads to liberal decisions.
In addition to the random variable T defined in (2.1), another commonly used
multivariate t variable is defined in the literature, e.g. by Tong [1990], p. 202.
For j = 1, . . . , N let Xj = (X1j, . . . , Xkj)′ be independent Nk(0,Σ) variables. For
i = 1, ..., k and
X¯i =
1
N
N∑
j=1
Xij, V
2
i =
1
N − 1
N∑
j=1
(Xij − X¯i)2
let
T ∗i =
√
NX¯i
Vi
(i = 1, ..., k). (2.4)
The random variable T ∗ = (T ∗1 , ..., T ∗k )′ is also called a multivariate t-variable. The
marginal distribution of
√
NX¯i/Vi is a t-distribution with N − 1 degrees of freedom
(i = 1, ..., k). While (2.1) takes the same χ2ν variable U for each component Ti, the
χ2N−1 variables (N − 1)V 2i in (2.4) are different because of their dependence on i.
For statistical testing, this implies the assumption of homogeneous variances for the
Xi in (2.1) and of heterogeneous variances for the X¯i in (2.4). Indeed, definition
(2.4) is most appropriate for many applications, e.g for the analysis of multiple
endpoints that may have different scales and hence different variances. However, this
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multivariate t variable is rarely described correctly in the literature. Furthermore,
standard statistical software is not able to calculate the related density function.
The following considerations and test procedures are hence all based on definition
(2.1).
2.3 Skew-normal and Skew-t Distribution
Currently, there is an increasing interest in the literature on parametric families
of multivariate normal distributions. The motivation is to introduce more flexible
parametric families that still retain similarity with the multivariate normal distri-
bution. The multivariate skew normal distribution can be viewed as a result of such
ambitions. Amongst others, it has been studied by Azzalini [2005], Azzalini and
Valle [1996] and Azzalini and Capitanio [2003]. An introduction into the topic is
given by
Lemma 2.3.1. If f0 is a one-dimensional probability density function symmetric
about zero, and G is a one-dimensional distribution function such that G′ exists and
is a density symmetric about zero, then
f(z) = 2f0(z)G{w(z)} (z ∈ R) (2.5)
is a density function for any odd function w(·).
f0 is the “basis” base density, G{w(x)} the “perturbation” function. The set of
“perturbed” densities always includes the “basis” density, since w(x) ≡ 0 yields
f0 = f . A simple method for random number generation is provided by
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Corollary. If X ∼ G′ and Y ∼ f0 are independent random variables, then
Z =

Y, X < w(Y )
−Y, otherwise
(2.6)
has density function (2.5). If Y ∼ f0 and Z ∼ f , then |Y | d= |Z|, where the notation
d
= denotes equality in distribution (the cumulative distribution functions are equal).
Among other properties, the result implies that all even moments of Y and Z are
the same.
On using Equation (2.5) with f0 = φ and G = Φ, the density function and the
distribution function of a N(0, 1) variate, respectively, and w(x) = αx, where α ∈ R,
we get the density
φ(z, α) = 2φ(z)Φ(αz) (z ∈ R), (2.7)
which is called SN distribution with shape parameter α, denoted by SN(α). If
Z ∼ SN(α) and Y = ξ + ωZ, where ξ ∈ R+, then we shall write Y ∼ SN(ξ, ω2, α).
The following properties for Equation (2.7) hold:
(a) If α = 0, we obtain the N(0, 1) density.
(b) If Z ∼ SN(α), then −Z ∼ SN(−α).
(c) As α→∞, (2.7) converges pointwise to the half-normal density, namely 2φ(z)
for z ≥ 0.
(d) If Z ∼ SN(α), then Z2 ∼ χ21.
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(e) For fixed α, (2.7) is strongly unimodal, i.e. log f(z, α) is a concave function
of z.
(f) The corresponding distribution function is given by
Φ(z, α) = Φ(z)− 2T (z, α),
where T (z, α) is the function studied by Owen [1956], and it satisfies the
relationship
Φ(z,−α) = 1− Φ(−z, α).
(g) If U ∼ N(0, 1) is independent of Z ∼ SN(α), then
aU + bZ√
a2 + b2
∼ SN
(
bα√
a2(1 + α2) + b2
)
(2.8)
for any a, b ∈ R.
The moment generating function of SN(ξ, ω2, α) is given by
M(t) = E
(
etY
)
= 2 exp
(
ξt+
ω2t2
2
)
Φ(δωt),
where δ = α/
√
1 + α2 ∈ (−1, 1). It follows that
E(Y ) = ξ + ωµz, V ar(Y ) = ω
2(1− µ2z),
γ1 =
4− pi
2
µ3z
(1− µ2z)3/2
, γ2 = 2(pi − 3) µ
4
z
(1− µ2z)2
,
where µz =
√
2/pi δ and γ1, γ2 denote the standardized third and fourth-order
cumulants, respectively. The range of γ1 is approximately (-0.9953, 0.9953).
The multivariate version is presented by
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Lemma 2.3.2. If f0 is a d-dimensional probability density function such that
f0(x) = f0(−x) for x ∈ Rd, G is a one-dimensional differentiable distribution func-
tion such that G′ is a density symmetric about 0, and w is a real-valued function
such that w(−x) = −w(x) for all x ∈ Rd, then
f(z) = 2f0(z)G{w(z)} (z ∈ Rd) (2.9)
is a density function on Rd.
Corollary. If X ∼ G′ and Y ∼ f0 are independent variables, then Z defined as in
Equation (2.6) has the distribution (2.9). If Y ∼ f0 and Z ∼ f , then t(Y ) d= t(Z)
for any real valued function such that t(x) = t(−x) for all x ∈ Rd, irrespective of
the choice of G and w.
Consider the case that f0(x) in Equation (2.9) is φd(x,Ω), the density function of
an Nd(0,Ω) variable, where Ω is a positive definite matrix. Also assume that G = Φ
and w is a linear function. Allowing for the presence of a d-dimensional location
parameter ξ, the density function is
f(y) = 2φd(y − ξ,Ω)Φ(α′ω−1(y − ξ)) (y ∈ Rd), (2.10)
where α ∈ Rd is the shape parameter and ω is the diagonal matrix formed by
the standard deviations of Ω. If a d-dimensional continuous random variable Y
has the density (2.10), we say that its distribution is multivariate SN and write
Y ∼ SNd(ξ,Ω,α). The moment generating function of SNd(ξ,Ω,α) is given by
M(t) = 2 exp
(
ξ′t+
1
2
t′Ωt
)
Φ(δ′ωt), t ∈ Rd, (2.11)
where δ = (1 + α′Ω¯α)−1/2Ω¯α and Ω¯ = ω−1Ωω−1 is the correlation matrix associ-
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ated with Ω. From (2.11), it follows that:
E(Y ) = ξ + ωµz, V ar(Y ) = Ω− ωµzµ′zω,
γ1,d =
(
4− pi
2
)2(
µ′zΩ¯
−1
µz
1− µ′zΩ¯−1µz
)3
, γ2,d = 2(pi − 3)
(
µ′zΩ¯
−1
µz
1− µ′zΩ¯−1µz
)2
,
where µz =
√
2/pi δ is the mean value of the reduced variable Z = ω−1(Y − ξ) ∼
SNd(0, Ω¯,α). γ1,d, γ2,d denote the multivariate indices of skewness and kurtosis
whose approximate ranges are (0, 0.9905) and (0, 0.869), respectively. Another
direct consequence of (2.11) is that the sum of a multivariate SN variate and an
independent multivariate normal variate is still SN . This fact is essentially the
multivariate version of property (2.8).
Like the considerations concerning the multivariate skew normal distribution there
is an analogous variant of the t-distribution. See Azzalini and Capitanio [2003] and
Azzalini [2005] therefore. A continuous random variable Y has a multivariate skew-t
distribution if its density is of type
fT (y) = 2td(y, ξ,Ω, ν)T1
(
α′ω−1(y − ξ)
(
ν + d
Qy + ν
)1/2
; ν + d
)
(y ∈ Rd),
(2.12)
where ξ, Ω and ω are as introduced above, Qy = (y − ξ)′Ω−1(y − ξ),
td(y, ξ,Ω, ν) =
Γ
(
1
2
(ν + d)
)
|Ω|1/2(piν)d/2Γ(1
2
ν)
1
(1 +Qy/ν)(ν+d)/2
is the density function of a d-dimensional t variate with ν degrees of freedom, and
T1(x; ν + d) denotes the scalar t-distribution function with ν + d degrees of free-
dom. We write Y ∼ ST (ξ,Ω,α, ν). Equation (2.12) can be generated by the same
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construction used for the regular multivariate t-distribution, namely
Y = ξ +
Z√
W/ν
, (2.13)
where W ∼ χ2ν , if Z is an independent variable which is now taken to be
SNd(0,Ω,α) in place of the Nd(0,Ω) distribution used to produce the regular t-
distribution. From (2.13) it follows that, if ν → ∞, Equation (2.12) converges to
the SN density (2.10). The relation
(Y − ξ)′Ω−1(Y − ξ)/d ∼ F (d, ν)
holds. Furthermore, unlimited range for the indices of skewness and kurtosis is
allowed for the individual components.
2.4 Distribution of Maximum and Minimum of Test
Statistics
A common starting point of many multiple test procedures is the use of a maximum
or a minimum of test statistics. According to Theorem 2.1.4, the proper choice
of a quantile c, coming from the distribution of maxs∈I Zs, guarantees the UIT to
be a level-α test. Thus, the problem is to derive the corresponding distributions.
Therefore, we have considered the skew normal and skew-t distribution. In this
section, we show their connections with the maximum and minimum of test statistics.
Primarily, explicit solutions have been known only for a few special cases. Tong
[1990] (p. 126) has considered the probability density function for the maximum
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of the components of an exchangeable multivariate normal random vector, i.e., its
covariance matrix is equicorrelated. The case of two random variables with a joint
bivariate normal distribution has been considered by Roberts [1966] and rediscovered
by Loperfido [2002]. Their proofs are omitted here again for brevity.
Theorem 2.4.1. Let the random variables X1, X2, Y1, Y2, Z1, Z2 be distributed as
follows:  X1
X2
 ∼ N

 0
0
 ;
 σ11 σ12
σ21 σ22

 ,
Y1√
σ11
∼ SN
(
σ11 − σ12√
σ11σ22 − σ212
)
,
Y2√
σ22
∼ SN
(
σ22 − σ12√
σ11σ22 − σ212
)
,
Z1√
σ11
∼ SN
(
σ12 − σ11√
σ11σ22 − σ212
)
,
Z2√
σ22
∼ SN
(
σ12 − σ22√
σ11σ22 − σ212
)
.
Then the distribution of max{X1, X2} is a mixture with equal weights of the distribu-
tions of Y1 and Y2. The distribution of min{X1, X2} is a mixture with equal weights
of the distributions of Z1 and Z2.
Theorem 2.4.2. Let X1, X2 be two standardized random variables whose distribu-
tion is jointly normal: X1
X2
 ∼ N

 0
0
 ;
 1 ρ
ρ 1

 .
Then the distributions of the random variables max{X1, X2} and min{X1, X2} are
skew-normal:
max{X1, X2} ∼ SN
(√
1− ρ
1 + ρ
)
, min{X1, X2} ∼ SN
(
−
√
1− ρ
1 + ρ
)
. (2.14)
Equations (2.13) and (2.14) lead to the next
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Corollary. Let X1, X2 be two random variables which are jointly central t-
distributed with ν degrees of freedom and correlation ρ. Then the distributions of
the random variables max{X1, X2} and min{X1, X2} are skew-t:
max{X1, X2} ∼ ST
(
ν,
√
1− ρ
1 + ρ
)
, min{X1, X2} ∼ ST
(
ν,−
√
1− ρ
1 + ρ
)
.
The generalization to k-variate random variables X = (X1, ..., Xk)′ is given by the
following results of Arellano-Valle and Genton [2008]. We do not introduce the
authors’ denotation here for simplicity. Also the proofs can be seen in their article.
Theorem 2.4.3. Let X = (X1, ..., Xk)′ ∼ Nk(µ,Σ). The probability density func-
tion fX(k) of X(k) = max{X1, ..., Xk} is
fX(k) =
k∑
i=1
φ1(x;µi,Σii)Φk−1
(
x1k−1;µ−i,i(x),Σ−i−i,i
)
(x ∈ R).
Theorem 2.4.4. Let X = (X1, ..., Xk)′ ∼ tk,µ(ν,Σ). The probability density func-
tion fX(k) of X(k) = max{X1, ..., Xk} is
fX(k) =
k∑
i=1
t1(x;µi,Σii, ν)Tk−1
(
x1k−1;µ−i,i(x),
ν + z2i
ν + 1
Σ−i−i,i, ν + 1
)
(x ∈ R).
2.5 Quantile Relations
Having seen that maximum and minimum of components of multivariate normal
and t-variables are SN and ST distributed, respectively, we now consider the related
quantiles, since they are needed for test decisions and confidence intervals. The
following considerations refer to the multivariate t- and the ST distribution, but are
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also valid for the multivariate normal distribution and the SN distribution, which
may be viewed as a special case with ν =∞.
LetX ∼ tk(ν,R) be a k-variate random vector. For the joint k-variate t-distribution,
we define
• the lower α-quantile tlk,α(ν,R), where
P
(⋂k
i=1{Xi ≤ tlk,α(ν,R)}
)
= α,
• the lower (1− α)-quantile tlk,1−α(ν,R), where
P
(⋂k
i=1{Xi ≤ tlk,1−α(ν,R)}
)
= 1− α,
• the upper α-quantile tuk,α(ν,R), where
P
(⋂k
i=1{Xi ≥ tuk,α(ν,R)}
)
= α,
• the upper (1− α)-quantile tuk,1−α(ν,R), where
P
(⋂k
i=1{Xi ≥ tuk,1−α(ν,R)}
)
= 1− α, and
• the two-sided (1− α)-quantile ttsk,1−α(ν,R), where
P
(⋂k
i=1{−ttsk,1−α(ν,R) ≤ Xi ≤ ttsk,1−α(ν,R)}
)
= 1− α.
Figure 2.2 illustrates these definitions for the bivariate case. A contour plot for a
bivariate t-variable is shown with ν = 20 and independent components, i.e., ρ = 0.
It is immediately clear that there are only three relevant quantiles in the univariate
2.5. QUANTILE RELATIONS 23
Figure 2.2: Upper, lower and two-sided quantiles for a bivariate t-distributed random
variable with ν = 20 and ρ = 0.
case because
tl1,1−α(ν,R) = t
u
1,α(ν,R) = tν,1−α,
tu1,1−α(ν,R) = t
l
1,α(ν,R) = tν,α,
tts1,1−α(ν,R) = tν,1−α/2.
Corresponding equalities do not hold for k > 1. The symmetry of the multivariate
t-distribution about zero also results in tlk,γ(ν,R) = −tuk,γ(ν,R) for any γ ∈ (0, 1).
The following theorem gives a connection between these quantiles and quantiles of
a ST distribution.
Theorem 2.5.1. LetX ∼ tk(ν,R) be a k-variate random vector and let stmaxα (ν,R),
stmax1−α(ν,R), stminα (ν,R), stmin1−α(ν,R) be appropriate quantiles of the distribution of
the maximum and minimum of the components of X, respectively. The following
properties are valid:
tlk,α(ν,R) = st
max
α (ν,R), t
l
k,1−α(ν,R) = st
max
1−α(ν,R),
tuk,α(ν,R) = st
min
1−α(ν,R), t
u
k,1−α(ν,R) = st
min
α (ν,R), (2.15)
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and
stmaxα (ν,R) = −stmin1−α(ν,R), stmax1−α(ν,R) = −stminα (ν,R). (2.16)
Proof. From the above definition, it follows that
α = P
(
k⋂
i=1
{Xi ≤ tlk,α(ν,R)}
)
= P
(
X1 < t
l
k,α(ν,R), ..., Xk < t
l
k,α(ν,R)
)
= P
(
max
i=1,...,k
{Xi} < tlk,α(ν,R)
)
= P
(
max
i=1,...,k
{Xi} < stmaxα (ν,R)
)
.
Hence tlk,α(ν,R) = stmaxα (ν,R). Furthermore,
α = P
(
k⋂
i=1
{Xi ≥ tuk,α(ν,R)}
)
= P
(
X1 > t
l
k,α(ν,R), ..., Xk > t
l
k,α(ν,R)
)
= P
(
min
i=1,...,k
{Xi} > tlk,α(ν,R)
)
= P
(
min
i=1,...,k
{Xi} > stmin1−α(ν,R)
)
.
Hence tuk,α(ν,R) = stmin1−α(ν,R). The other relations given in (2.15) can be de-
rived similarly. Equation (2.16) follows from the symmetry of the multivariate t-
distribution about zero.
Theorem 2.5.1 implies that we do not have to know the exact (skewed) distribution of
the maximum and minimum of the test statistics. It is sufficient to know their joint
multivariate distribution, because the quantiles coincide. Figure 2.3 illustrates this
relation for the bivariate case. LetX be a bivariate-t random vector with 20 degrees
of freedom and uncorrelated components. The first row of the figure shows a contour
plot of the distribution of X, the second row the related skewed distributions of
min{X1, X2} and max{X1, X2}. The connection between the quantiles of the skewed
distributions and the related bivariate distributions can easily be seen. Hence, the
quantiles tlk,1−α(ν,R), tuk,1−α(ν,R) and ttsk,1−α(ν,R) are necessary for decisions in a
UIT.
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Figure 2.3: Connection between the quantiles of the skewed distributions of
max{X1, X2} or min{X1, X2} and the joint bivariate distributions of their com-
ponents, respectively.
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The next statements provide information about the dependence of the quantiles on
the dimension of their distribution (number of components) and correlations.
Theorem 2.5.2. Let X ∼ tk(ν,R) be a k-variate random vector. The following
properties are valid if ρij = ρ for all i 6= j:
tlk,1−α(ν,R) < t
l
k+1,1−α(ν,R),
tuk,1−α(ν,R) > t
u
k+1,1−α(ν,R),
ttsk,1−α(ν,R) < t
ts
k+1,1−α(ν,R).
Proof. The probability that the maximum of k random variables is larger than a
fixed quantile c increases with increasing k,
P
(
max
i=1,...,k
{Xi} > c
)
≤ P
(
max
i=1,...,k+1
{Xi} > c
)
.
Fixing both probabilities at level 1 − α, the related quantiles tlk,1−α(ν,R) and
tlk+1,1−α(ν,R) cannot be equal, and it follows that tlk,1−α(ν,R) < tlk+1,1−α(ν,R).
Otherwise, the probability that the minimum of k random variables is smaller than
a fixed quantile c also increases with increasing k,
P
(
min
i=1,...,k
{Xi} < c
)
≤ P
(
min
i=1,...,k+1
{Xi} < c
)
.
We analogously obtain tuk,1−α(ν,R) > tuk+1,1−α(ν,R). And finally, the probability
that both the maximum of k random variables is larger than any fixed quantile c,
and the minimum of k random variables is smaller than any fixed quantile −c, also
increases with increasing k,
P
(
max
i=1,...,k
{|Xi|} > c
)
≤ P
(
max
i=1,...,k+1
{|Xi|} > c
)
.
It follows that ttsk,1−α(ν,R) < ttsk+1,1−α(ν,R).
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Theorem 2.5.3. Let X ∼ tk(ν,R) be a k-variate random vector with ρij = ρ for
all i 6= j.
1. For ρ = ρmin (Equation (2.3)), tlk,1−α(ν,R) has its maximal value, tuk,1−α(ν,R)
its minimal value, and
tlk,1−α(ν,R) ≤ tν,1−α/k, tuk,1−α(ν,R) ≥ tν,α/k.
2. For ρ = 0, ttsk,1−α(ν,R) has its maximal value.
3. For ρ = 1,
tlk,1−α(ν,R) = tν,1−α, t
u
k,1−α(ν,R) = tν,α.
Corollary. Let X ∼ tk(ν,R) be a k-variate random vector. The following conclu-
sions hold for k > 2:
tν,1−α ≤ tlk,1−α(ν,R) < tν,1−α/k,
tν,α ≥ tuk,1−α(ν,R) > tν,α/k,
tν,1−α/2 ≤ ttsk,1−α(ν,R) < tν,α/2k.
For k = 2, ≤ holds instead of < for tlk,ν,1−α(ν,R), and ≥ for tuk,ν,1−α(ν,R).
Theorem 2.5.3 is without proof but Figure 2.4 illustrates the dependence of k-variate
t-quantiles on the correlation (ρij = ρ for all i 6= j) and their relation to univariate
t-quantiles. The first row shows lower (1 − α)-quantiles, the second one two-sided
(1 − α)-quantiles. The columns split up the dimensions k = 2, 4, 8. The Figures
2.5, 2.6 and 2.7 illustrate the dependence of the quantiles tlk,1−α(ν,R) of a trivari-
ate t-distribution (with ν = 20) on the correlation of its components. The black
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Figure 2.4: Dependence of k-variate t-quantiles on the correlation and their relation
to univariate t-quantiles; ν = 20, α = 0.05.
dots in these plots represent a cutout of α = 0.05 of the entire probability mass by
tlk,1−α(ν,R) for maximal negative (red), no (green) and maximal (blue) equicorre-
lation, respectively. According to Section 2.2, the red points in Figure 2.5 form a
cutout of a disk, a cutout of a ball in Figure 2.6, and a ray in Figure 2.7. When
there is maximal negative correlation, no probability mass is located in the first or-
thant. The related quantile does not cut very deeply into the probability space and
is largest here. For increasing correlation, more and more probability mass moves
into the first orthant, and the quantile becomes smaller. Having maximal positive
correlation, 50% of the probability mass lies exactly on a ray from the origin to
infinity. Here, the quantile is smallest.
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Figure 2.5: Trivariate t-distributed random variables with ν = 20 and maximal
negative correlation ρ = −1
2
, black points represent a cutout of 5%.
Figure 2.6: Trivariate t-distributed random variables with ν = 20 and correlation
ρ = 0, black points represent a cutout of 5%.
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Figure 2.7: Trivariate t-distributed random variables with ν = 20 and maximal
positive correlation ρ = 1, black points represent a cutout of 5%.
A consequence of these considerations is that the use of a Bonferroni adjustment for
decisions in a one-sided UIT is almost correct for maximal negative equicorrelated
local comparisons and most conservative for maximal positive ones. Bonferroni-
adjusted two-sided UIT are least conservative for uncorrelated local comparisons
and most conservative for high absolute values of the correlations.
Chapter 3
Multiple Contrast Tests in the
Presence of Heteroscedasticity
3.1 Introduction
MCTs and related SCIs are well-known methods for testing and estimating linear
functions of means – i.e. contrasts – of normally distributed populations. A broad
class of testing problems can be handled by them in modeling suitable contrast coef-
ficients. The many-to-one comparison of Dunnett [1955] is one of the most frequently
applied and cited testing procedures today. Several treatments are compared with
one control and tested for deviation. This can be translated by related contrast
coefficients and represents a very simple example. The all-pair comparison of Tukey
[1953], comparing all treatments against each other, is also a very famous example.
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Bretz [2006] has formulated the trend test of Williams [1971] as an approximate
MCT. Here, the contrast coefficients depend in addition on the sample sizes of the
treatment groups. Moreover, other interesting, problem-specific contrasts can be
created (see Westfall [1997]). Furthermore, MCTs and SCIs are also available for
ratios of means; see Dilba et al. [2004]. They are used if conclusions about ratios
rather than differences of means are of interest. That is, if relative changes, e.g. in
per cent, are to be analyzed.
The resulting MCTs and SCIs assume homogeneous variances for the data. This
condition is necessary for the derivation of a joint multivariate t-distribution of the
test statistics. If not fulfilled, this distribution is not available. Nevertheless, an ad-
justment for heteroscedastic data is necessary. Dose finding studies often have the
problem of heteroscedasticity because the variance of the data depends on the dose
effect. The data of Westfall [1997] (in Section 3.6.1), Adler and Kliesch [1990] (in
Section 3.6.2) or Silva-Costa-Gomes et al. [2005] (in Hasler et al. [2008]) are exam-
ples. The first adjustment regarding heteroscedasticity for tests of any contrasts of
means from normally distributed data has been made by Satterthwaite [1946]. Like
Welch [1938], he approximates the degrees of freedom of the resulting t-distribution
by matching first and second moments. Games and Howell [1976] used this ap-
proach for all-pair comparisons. Many other procedures have been suggested and
investigated. Most of them have been developed for special contrasts only, or tend
to achieve conservative or liberal tests depending on the extent of heteroscedasticity
(see, e.g., Dunnett [1980]). Other approaches – from Welch [1951] or Brown and
Forsythe [1974] – are based on F -distributions. This work presents three versions
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of a general approach that handles the entire family of MCTs for differences and
ratios of means using multivariate t-distributions, and against the background of
controlling the FWE at level α.
In Section 3.2, the testing problem is formulated, and an adequate test statistic and
distribution parameters are derived using several methods. Section 3.3 shows results
of α-simulations for several contrasts and key settings. SCIs are treated in Section
3.4, power considerations in 3.5. Examples are given in Section 3.6.
3.2 Test Procedure
3.2.1 Differences of Means
For h = 1, . . . , p and j = 1, . . . , nh, let Xhj denote the jth observation under the hth
treatment in a one-way layout. Suppose the Xhj to be independently normal with
means µh and variances σ2h, thus
Xhj ∼ ⊥N(µh, σ2h) (h = 1, . . . , p, j = 1, . . . , nh).
Let µ = (µ1, . . . , µk)′ be the vector of treatment means and X¯ = (X¯1, . . . , X¯k)′ its
estimator with
X¯h =
1
nh
nh∑
j=1
Xhj (h = 1, . . . , p).
The sample variances are given by
S2h =
1
nh − 1
nh∑
j=1
(Xhj − X¯h)2 (h = 1, . . . , p).
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We are interested in the vector of contrasts η = (η1, . . . , ηq)′, where
ηl =
p∑
h=1
clhµh
= c′lµ (l = 1, . . . , q).
The vectors cl = (cl1, . . . , clp)′ consist of real constants with
∑p
h=1 clh = 0 (l =
1, . . . , q). Without loss of generality, the objective is to test the hypotheses
H0l : ηl ≤ δl (l = 1, . . . , q) (3.1)
for specified absolute thresholds δl. Usually, δl = 0 for all l = 1, . . . , q. This testing
problem is a UIT because the overall null hypothesis of interest can be expressed as
an intersection of these local null hypotheses, that is,
H0 =
q⋂
l=1
H0l.
Figure 3.1 shows the parameter space of testing problem (3.1) for the case where
q = 2 contrasts are of interest. For the further development, we reshape (3.1) and
set
ψl =
(
p∑
h=1
clhµh
)
− δl
= c′lµ− δl (l = 1, . . . , q)
with estimator
ψˆl =
(
p∑
h=1
clhX¯h
)
− δl
= c′lX¯ − δl (l = 1, . . . , q).
We have
V ar(ψˆl) =
p∑
h=1
c2lhσ
2
h/nh
= c′lVMcl (l = 1, . . . , q),
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Figure 3.1: Parameter space of the one-sided MCT for differences with q = 2 con-
trasts.
with M and V defined by
M =

1/n1 0
. . .
0 1/np
 and V =

σ21 0
. . .
0 σ2p
 ,
respectively. Consequently, we obtain the vector of test statistics T = (T1, . . . , Tq)′,
where
Tl =
(∑p
h=1 clhX¯h
)− δl√∑p
h=1 c
2
lhS
2
h/nh
=
c′lX¯ − δl√
c′lVˆ Mcl
(l = 1, . . . , q) (3.2)
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and
Vˆ =

S21 0
. . .
0 S2p
 .
If the group variances are homogeneous, σ21, . . . , σ2k = σ2, V and Vˆ can be reduced
to the scalars σ2 and S2, respectively, with
S2 =
∑p
h=1(nh − 1)S2h∑p
h=1(nh − 1)
. (3.3)
In the presence of heterogeneous variances, we cannot derive an exact joint multivari-
ate t-distribution for (T1, . . . , Tq)′. Numerator and denominator in (3.2) are indeed
stochastically independent, but the denominator is a mixture of σ2hχ2-distributions
(h=1,. . . ,p). The marginal distribution of each Tl can be approximated by a t-
distribution using the idea of Welch [1938] and Satterthwaite [1946]. Denote the
squared denominator of (3.2) as ζl. Of course, ζl depends on the estimates S2h
(h = 1, . . . , p). The aim is to approximate the distribution of ζl by that of a χ2(νl)
variable, multiplied by σ
2
l
νl
, where σ2l and νl are chosen such that the first two mo-
ments of ζl agree with the first two moments of
σ2l
νl
χ2(νl). We have
ζl =
p∑
h=1
c2lhS
2
h
nh
,
Eζl =
p∑
h=1
c2lhσ
2
h
nh
, (3.4)
V arζl =
p∑
h=1
2c4lhσ
4
h
n2h(nh − 1)
. (3.5)
While (3.4) is obvious, (3.5) results from the following
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Proof.
V arζl =
p∑
h=1
c4lh
n2h
V ar
(
S2h
)
=
p∑
h=1
c4lh
n2h(nh − 1)2
V ar
(
nh∑
j=1
(Xhj − X¯h)2
)
=
p∑
h=1
c4lh
n2h(nh − 1)2
V ar
(
nh∑
j=1
σ2h
(
Xhj − X¯h
σh
)2)
=
p∑
h=1
c4lhσ
4
h
n2h(nh − 1)2
V ar
(
nh∑
j=1
(
Xhj − X¯h
σh
)2)
=
p∑
h=1
c4lhσ
4
h
n2h(nh − 1)2
2(nh − 1)
=
p∑
h=1
2c4lhσ
4
h
n2h(nh − 1)
Furthermore,
E
(
σ2l
νl
χ2(νl)
)
=
σ2l
νl
νl = σ
2
l ,
V ar
(
σ2l
νl
χ2(νl)
)
=
σ4l
ν2l
2νl = 2
σ4l
νl
.
The system of equations
p∑
h=1
c2lhσ
2
h
nh
= σ2l ,
p∑
h=1
2c4lhσ
4
h
n2h(nh − 1)
= 2
σ4l
νl
yields
p∑
h=1
2c4lhσ
4
h
n2h(nh − 1)
= 2
(
p∑
h=1
c2lhσ
2
h
nh
)2
1
νl
and
νl =
(∑p
h=1
c2lhσ
2
h
nh
)2
∑p
h=1
c4lhσ
4
h
n2h(nh−1)
.
38 CHAPTER 3. MCTS IN THE PRESENCE OF HETEROSCEDASTICITY
Replacement of the unknown parameters σ2h with the estimators S2h (h = 1, . . . , p)
leads to1
νˆl =
(∑p
h=1
c2lhS
2
h
nh
)2
∑p
h=1
c4lhS
4
h
n2h(nh−1)
. (3.6)
Hence, under H0l, Tl approximately follows a t-distribution with νˆl degrees of free-
dom. For an approximate joint distribution, we have to determine a suitable corre-
lation matrix. We have
Cov
(
p∑
h=1
clhX¯h,
p∑
h=1
cl′hX¯h
)
= E
(
p∑
h=1
clhX¯h − E
p∑
h=1
clhX¯h
)(
p∑
h=1
cl′hX¯h − E
p∑
h=1
cl′hX¯h
)
= E
(
p∑
h=1
clh
(
X¯h − EX¯h
))( p∑
h=1
cl′h
(
X¯h − EX¯h
))
= E
p∑
h=1
p∑
h′=1
clhcl′h′
(
X¯h − EX¯h
) (
X¯h′ − EX¯h′
)
=
p∑
h=1
p∑
h′=1,h′=h
clhcl′h′E
(
X¯h − EX¯h
) (
X¯h′ − EX¯h′
)
+
p∑
h=1
p∑
h′=1,h′ 6=h
clhcl′h′E
(
X¯h − EX¯h
) (
X¯h′ − EX¯h′
)
=
p∑
h=1
clhcl′hE
(
X¯h − EX¯h
)2
+
p∑
h=1
clhE
(
X¯h − EX¯h
) p∑
h′=1,h′ 6=h
cl′h′E
(
X¯h′ − EX¯h′
)
=
p∑
h=1
clhcl′hE
(
X¯h − EX¯h
)2
=
p∑
h=1
clhcl′hV arX¯h
=
p∑
h=1
clhcl′h
σ2h
nh
1The degrees of freedom in (3.6) and later in (3.12) must be greater than or equal to 2 for a
well defined distribution.
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Thus, it follows that
ρll′ =
∑p
h=1 clhcl′hσ
2
h/nh√
(
∑p
h=1 c
2
lhσ
2
h/nh) (
∑p
h=1 c
2
l′hσ
2
h/nh)
=
c′lVMcl′√
c′lVMcl
√
c′l′VMcl′
(1 ≤ l, l′ ≤ q). (3.7)
Hence, T1, . . . , Tq follow an unknown joint q-variate distribution with correlation
matrix R = (ρll′)l,l′ . It is clearly not related to a q-variate t-distribution in the sense
of existing definitions because it additionally depends on the unknown variances σ2h
and on several degrees of freedom νl. This problem has not been solved so far, and
hence some approximate approach has to be followed.
Games and Howell [1976] were the first to use a test statistic without a pooled
variance estimator, but with individual variance estimators S2h for the all-pair com-
parison procedure. Formula (3.2) can be seen as a generalization of their test statis-
tic for all MCTs. The authors have applied studentized range distributions with
comparison-specific degrees of freedom according to (3.6). The problem of calculat-
ing the correlations from (3.7) is clearly that V is unknown. Games and Howell have
effectively replaced V with the unit matrix, which leads to the same correlations
as if homogeneous group variances were assumed. This procedure is referred to as
the GH procedure in the following. Some articles were already concerned with the
procedure of Games and Howell (e.g., Tamhane [1979] and Dunnett [1980]). Expect-
edly, their method can lead to both conservative or liberal test decisions depending
on the amount of heteroscedasticity and the sample allocation. Another approach
is the use of the matrix Vˆ instead of V in (3.7). This means to plug-in the vari-
ance estimators S2h and it yields the estimated correlation matrix Rˆ = (ρˆll′)l,l′ with
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elements
ρˆll′ =
∑p
h=1 clhcl′hS
2
h/nh√
(
∑p
h=1 c
2
lhS
2
h/nh) (
∑p
h=1 c
2
l′hS
2
h/nh)
=
c′lVˆ Mcl′√
c′lVˆ Mcl
√
c′l′Vˆ Mcl′
(1 ≤ l, l′ ≤ q).
We refer to this plug-in procedure as PI. Because of an unknown joint distribution
for T1, . . . , Tq, both GH and PI use q several approximate q-variate t-distributions
to come to a test decision about testing problem (3.1). Hence, each single test
statistic Tl is related to “its own” distinct q-variate t-distribution with correlation
matrix Rˆ and degree of freedom νˆl coming from (3.6). That results in different,
non-equidistant quantiles for the test decisions.
Dunnett [1985] has considered the use of both the geometric and arithmetic mean
of the correlations, respectively, for comparisons with a control in the context of
unbalanced one-way layouts in the homoscedastic case. Hochberg and Tamhane
[1987] have suggested the arithmetic mean, as well as Dunnett [1985], because it
provides a less conservative approximation. That is,
ρ¯ll′ =
1
q2 − q
q∑
l 6=l′=1
ρˆll′ for all 1 ≤ l 6= l′ ≤ q.
Tamhane and Logan [2004] resort to this approach even in the case of heteroscedastic
data. Furthermore, they recommend to use the average of the degrees of freedom,
ν¯ =
1
q
q∑
l=1
νˆl.
The resulting procedure for all MCTs is referred to as HTL in the following. Note
that HTL uses a single, approximate joint q-variate t-distribution of T1, . . . , Tq which
is explicitly avoided by the GH and PI procedures.
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Besides, let us denote the procedure for homogeneous variances by HOM. Here, the
same correlation matrix as for GH is used, but only a single degree of freedom
ν =
p∑
h=1
(nh − 1),
and the pooled variance estimator (3.3) for the test statistic (3.2) is used instead of
the individual variance estimators S2h.
The decision rule for testing problem (3.1) is to reject H0l for each contrast ηl with
Tl > t
l
q,1−α(.), (3.8)
where tlq,1−α(.) is a lower (1−α)-quantile of (one or q) related q-variate t-distributions.
If two-sided testing is of interest, the absolute values for Tl, and quantiles ttsq,1−α(.)
have to be taken. For the computation of these quantiles, one may resort to the
numerical integration routines of Genz and Bretz [1999, 2002], see also Bretz et al.
[2001]. Their algorithm is not restricted to special correlation structures. Related
adjusted p-values per comparison can also be obtained, of course.
Let us finally point out that HOM and HTL are simultaneous test procedures in the
sense of Gabriel [1969], while GH and PI are not, because the Tl (l = 1, . . . , q) are
compared with different quantiles. Since all of these procedures are UIT, Theorem
2.1.3 holds and they are thus coherent and consonant. That means, if any local
hypothesis H0l (l = 1, . . . , q) is rejected, H0 is, too. On the other hand, if H0 is
rejected, at least one H0l must be rejected.
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3.2.2 Ratios of Means
The same assumptions are made as in Section 3.2.1. Furthermore, let the means
µ1, . . . , µk have the same algebraic sign. We are interested now in the vector of ratios
of contrasts γ = (γ1, . . . , γq)′, where
γl =
∑p
h=1 clhµh∑p
h=1 dlhµh
=
c′lµ
d′lµ
(l = 1, . . . , q).
The vectors cl = (cl1, . . . , clp)′ and dl = (dl1, . . . , dlp)′ consist of real constants.
Without loss of generality, the hypotheses to be tested are
H0l : γl ≤ θl (l = 1, . . . , q) (3.9)
for specified relative thresholds θl.Usually, θl = 1 for all l = 1, . . . , q. Like testing
problem (3.1), this one is a UIT, and
H0 =
q⋂
l=1
H0l.
Figure 3.2 shows the parameter space of testing problem (3.9) when q = 2 contrasts
are of interest. We reshape (3.9) and set
ψl =
p∑
h=1
clhµh − θl
p∑
h=1
dlhµh =
p∑
h=1
(clh − θldlh)µh
= (cl − θldl)′µ (l = 1, . . . , q)
with estimator
ψˆl =
p∑
h=1
(clh − θldlh) X¯h
= (cl − θldl)′ X¯ (l = 1, . . . , q).
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Figure 3.2: Parameter space of the one-sided MCT for ratios with q = 2 contrasts.
Since
V ar(ψˆl) =
p∑
h=1
(clh − θldlh)2 σ2h/nh
= (cl − θldl)′ VM (cl − θldl) (l = 1, . . . , q),
we obtain the vector of test statistics T = (T1, . . . , Tq)′, where
Tl =
∑p
h=1 (clh − θldlh) X¯h√∑p
h=1 (clh − θldlh)2 S2h/nh
=
(cl − θldl)′ X¯√
(cl − θldl)′ Vˆ M (cl − θldl)
(l = 1, . . . , q). (3.10)
Now, the same considerations as in the case of differences lead to
ζl =
p∑
h=1
(clh − θldlh)2 S2h
nh
,
Eζl =
p∑
h=1
(clh − θldlh)2 σ2h
nh
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and
V arζl =
p∑
h=1
2 (clh − θldlh)4 σ4h
n2h(nh − 1)
.
The system of equations
p∑
h=1
(clh − θldlh)2 σ2h
nh
= σ2,
p∑
h=1
2 (clh − θldlh)4 σ4h
n2h(nh − 1)
= 2
σ4
νl
yields
νl =
(∑p
h=1
(clh−θldlh)2σ2h
nh
)2
∑p
h=1
(clh−θldlh)4σ4h
n2h(nh−1)
. (3.11)
Replacement of the unknown parameters σ2h with the estimators S2h (h = 1, . . . , p)
leads to
νˆl =
(∑p
h=1
(clh−θldlh)2S2h
nh
)2
∑p
h=1
(clh−θldlh)4S4h
n2h(nh−1)
. (3.12)
Hence, under H0l, Tl approximately follows a t-distribution with νˆl degrees of free-
dom. Correspondingly, the required covariances are
Cov
(
p∑
h=1
(clh − θldlh) X¯h,
p∑
h=1
(cl′h − θl′dl′h) X¯h
)
=
p∑
h=1
(clh − θldlh) (cl′h − θl′dl′h) σ
2
h
nh
,
which leads to
ρll′ =
∑p
h=1 (clh − θldlh) (cl′h − θl′dl′h)σ2h/nh√(∑p
h=1 (clh − θldlh)2 σ2h/nh
) (∑p
h=1 (cl′h − θl′dl′h)2 σ2h/nh
)
=
(cl − θldl)′ VM (cl′ − θl′dl′)√
(cl − θldl)′ VM (cl − θldl)
√
(cl′ − θl′dl′)′ VM (cl′ − θl′dl′)
(3.13)
(1 ≤ l, l′ ≤ q)
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and
ρˆll′ =
∑p
h=1 (clh − θldlh) (cl′h − θl′dl′h)S2h/nh√(∑p
h=1 (clh − θldlh)2 S2h/nh
) (∑p
h=1 (cl′h − θl′dl′h)2 S2h/nh
)
=
(cl − θldl)′ Vˆ M (cl′ − θl′dl′)√
(cl − θldl)′ Vˆ M (cl − θldl)
√
(cl′ − θl′dl′)′ Vˆ M (cl′ − θl′dl′)
(3.14)
(1 ≤ l, l′ ≤ q).
Hence, T1, . . . , Tq follow an unknown joint q-variate distribution with correlation
matrix R = (ρll′)l,l′ . The procedures HOM, GH, PI and HTL can now be defined in
the same manner as in the case of differences of means. The decision rule for testing
problem (3.9) is also the same. H0l is rejected for each ratio of contrasts γl for which
(3.8) holds.
3.3 α-simulations
The aim of adjusting the degrees of freedom and the correlations between the con-
trasts is to control the FWE, balancing conservative and liberal behavior. All
methods described in Section (3.2) are approximate ones, so their quality must
be validated by simulations. For both difference-based (Section 3.3.1) and ratio-
based (Section 3.3.2) MCTs, respectively, three treatments have been compared in
a first simulation study, five in a second one. The first treatment is regarded as the
(negative) control. The FWE has been simulated; the nominal level is 0.05. Four
different settings have been considered, each setting with a total sample size of 30
(three treatments) and 50 (five treatments), respectively. They are:
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a) a balanced allocation; the last group has the largest standard deviation:
nh : 10, 10, 10, σh : 10, 10, 50,
nh : 10, 10, 10, 10, 10, σh : 10, 10, 10, 10, 50,
b) the first group (control) has the smallest sample size; the last group has the
largest standard deviation:
nh : 4, 13, 13, σh : 10, 10, 50,
nh : 6, 11, 11, 11, 11, σh : 10, 10, 10, 10, 50,
c) the last group has the smallest sample size; the last group has the largest
standard deviation:
nh : 13, 13, 4, σh : 10, 10, 50,
nh : 11, 11, 11, 11, 6, σh : 10, 10, 10, 10, 50,
d) a balanced allocation; the homoscedastic case:
nh : 10, 10, 10, σh : 30, 30, 30,
nh : 10, 10, 10, 10, 10, σh : 30, 30, 30, 30, 30.
The expected values of the treatment groups for the difference-based MCTs are
equal, that is µh = 100 (h = 1, . . . , p). For the ratio-based MCTs they are µ1 = 100
and µh = 125 (h = 2, . . . , p), and θl = 1.25 (l = 1, . . . , q). The value 100 has been
chosen (usually zero) because the sample means should not have different algebraic
signs when considering ratios. The settings a), b) and c) imply very high standard
deviations for the last group, i.e. a coefficient of variation of 50% for the control
group, to intensify possible differences between the procedures. All the following
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simulation results have been obtained from 100000 simulation runs, with the same
starting seed (seed 10000), using a program code in the statistical software R [2008],
package mvtnorm [Genz et al., 2008, Hothorn et al., 2001].
3.3.1 Differences of Means
We have considered five one-sided difference-based MCT problems which are all re-
lated to the hypotheses (3.1): Dunnett, Tukey2, Williams, Changepoint, and Aver-
age. Table 3.1 (3.2) shows the results of the first (second) study for difference-based
MCTs with three (five) treatments. Depending on the setting, GH and HTL tend to
either conservatism or liberalism, respectively. Setting c) for three treatments (Table
3.1), combining the smallest sample size and the highest standard deviation, leads
to especially liberal behavior for HTL (0.078 for the Dunnett contrast). This is not
so obvious for five treatments (Table 3.2) because the part of treatments with equal
variances is higher there. One can also see from Table 3.2 that the Tukey contrast
generally seems to cause conservatism for HTL (0.036 for setting a)). GH seems to
deviate from the nominal α-level independent of the setting, but it depends more
strongly on the particular contrasts. The lowest level is achieved for the Change-
point contrast (0.034 for setting a), Table 3.2). Therefore, these procedures cannot
be recommend without reservations. With few exceptions, PI maintains the α-level
exactly. It only varies from 0.047 to 0.055, while GH has ranges from 0.034 to 0.062,
and HTL from 0.036 to 0.078. HOM is liberal for setting a), where the sample sizes
2Normally, a Tukey MCT is a two-sided test problem. For reasons of consistency, this fact is
disregarded.
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Setting MCT HOM GH PI HTL
Dunnett 0.063 0.053 0.049 0.051
Tukey 0.059 0.042 0.049 0.041
a) Williams 0.073 0.043 0.049 0.050
Changepoint 0.088 0.038 0.049 0.050
Average 0.076 0.044 0.048 0.046
Dunnett 0.011 0.062 0.052 0.055
Tukey 0.031 0.050 0.055 0.050
b) Williams 0.015 0.049 0.050 0.050
Changepoint 0.047 0.041 0.051 0.050
Average 0.044 0.044 0.050 0.044
Dunnett 0.208 0.054 0.051 0.078
Tukey 0.211 0.043 0.048 0.061
c) Williams 0.213 0.045 0.049 0.059
Changepoint 0.222 0.042 0.048 0.059
Average 0.248 0.053 0.054 0.070
Dunnett 0.049 0.048 0.048 0.048
Tukey 0.049 0.049 0.049 0.045
d) Williams 0.049 0.050 0.050 0.050
Changepoint 0.049 0.050 0.050 0.049
Average 0.049 0.050 0.050 0.049
Table 3.1: FWE of one-sided MCTs (differences) for p = 3 treatments, several
contrasts, procedures and settings; µ = (100, 100, 100)′, α = 0.05.
3.3. α-SIMULATIONS 49
Setting MCT HOM GH PI HTL
Dunnett 0.081 0.055 0.051 0.051
Tukey 0.077 0.043 0.051 0.036
a) Williams 0.104 0.043 0.049 0.049
Changepoint 0.129 0.034 0.049 0.049
Average 0.114 0.042 0.047 0.046
Dunnett 0.050 0.058 0.049 0.048
Tukey 0.065 0.045 0.052 0.039
b) Williams 0.070 0.051 0.053 0.050
Changepoint 0.115 0.035 0.051 0.049
Average 0.101 0.043 0.049 0.048
Dunnett 0.162 0.056 0.053 0.060
Tukey 0.159 0.043 0.051 0.041
c) Williams 0.184 0.045 0.050 0.054
Changepoint 0.197 0.036 0.048 0.051
Average 0.188 0.046 0.049 0.058
Dunnett 0.048 0.049 0.048 0.048
Tukey 0.050 0.051 0.052 0.043
d) Williams 0.050 0.050 0.049 0.048
Changepoint 0.049 0.052 0.052 0.052
Average 0.050 0.053 0.053 0.050
Table 3.2: FWE of one-sided MCTs (differences) for p = 5 treatments, several
contrasts, procedures and settings; µ = (100, 100, 100, 100, 100)′, α = 0.05.
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are balanced (0.114 for the Average contrast, Table 3.2), but most liberal for setting
c), where the smallest sample size and the highest standard deviation are combined
(0.248 for the Average contrast, Table 3.1). Setting b) causes conservativism for
three treatments (0.011 for the Dunnett contrast, Table 3.1), and liberalism for five
(0.115 for the Changepoint contrast, Table 3.2). The reason lies in the different rela-
tions between variances and sample sizes in setting b) for three and five treatments,
respectively.
We have again treated the situation of the Dunnett contrast to get an impression of
the strong control of the FWE. Let the first comparison be known to reject its local
null hypothesis because the second treatment significantly differs from the remaining
ones, i.e., µ2 = 1000. Only the FWE of the remaining comparisons, denoted by local
FWE, has been considered. Tables 3.3 and 3.4 show the α-level of these procedures
ignoring the second treatment. HOM clearly fails for setting a) (0.080, Table 3.4) and
c) (0.207, Table 3.3), but HTL also fails for setting c) for three treatments (0.059,
Table 3.3). All procedures applied are similar to those applied in the preceding
Setting HOM GH PI HTL
a) 0.063 0.028 0.026 0.029
b) 0.011 0.031 0.026 0.022
c) 0.207 0.028 0.027 0.059
d) 0.028 0.027 0.027 0.027
Table 3.3: Local FWE of one-sided MCTs (differences) for p = 3 treatments, the
Dunnett contrast, several procedures and settings; µ = (100, 1000, 100)′, α = 0.05.
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Setting HOM GH PI HTL
a) 0.080 0.043 0.039 0.040
b) 0.050 0.050 0.043 0.041
c) 0.162 0.045 0.042 0.051
d) 0.040 0.040 0.040 0.040
Table 3.4: Local FWE of one-sided MCTs (differences) for p = 5 treatments, the
Dunnett contrast, several procedures and settings; µ = (100, 1000, 100, 100, 100)′,
α = 0.05.
simulation.
3.3.2 Ratios of Means
Here, we focus only on one-sided ratio-based Dunnett MCT problems related to
the hypotheses (3.9). Table 3.5 (3.6) shows the results of the first (second) study
for ratio-based Dunnett MCTs with three (five) treatments. The procedures GH
and HTL tend to liberalism here. As in the case of differences, setting c) for three
treatments leads to liberal behavior for HTL (0.077, Table 3.5), but also for five
treatments (0.059, Table 3.6). GH is most liberal for setting b) (0.065, Table 3.5).
These procedures cannot be recommended without reservations. PI seems to main-
tain the α-level exactly and just as well as in the case of differences. It varies from
0.049 to 0.053 while GH has ranges from 0.049 to 0.065, and HTL from 0.049 to
0.077. HOM is liberal for setting a) with five treatments (0.063, 3.6), and gener-
ally most liberal for setting c) (0.197, Table 3.5). Setting b) causes conservativism,
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Setting HOM GH PI HTL
a) 0.047 0.056 0.050 0.051
b) 0.006 0.065 0.053 0.059
c) 0.197 0.055 0.051 0.077
d) 0.049 0.049 0.049 0.049
Table 3.5: FWE of one-sided MCTs (ratios) for p = 3 treatments, the Dunnett
contrast, several procedures and settings; µ = (100, 125, 125)′, θ = (1.25, 1.25),
α = 0.05.
especially for three treatments (0.006, Table 3.5).
For an appreciation of the strong control of the FWE, we have proceeded similarly
as in the case of differences above. Let the second treatment significantly differ from
the remaining ones, i.e., µ2 = 1000. Only the FWE of the remaining comparisons
(local FWE) has been considered. Tables 3.7 and 3.8 show the α-level of these
procedures ignoring the second treatment. HOM clearly fails for setting c) (0.195)
in Table 3.7 and for setting a) (0.064) and c) (0.147) in Table 3.8, HTL for setting
c) (0.058) in Table 3.7. Again, the procedures applied are similar to those applied
in the preceding simulation.
3.3.3 Conclusions
The reason why the procedures differ in their behavior becomes clearer when having
a look at the parameters of the underlying distributions. As an example, take
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Setting HOM GH PI HTL
a) 0.063 0.056 0.050 0.050
b) 0.034 0.062 0.050 0.049
c) 0.146 0.057 0.052 0.059
d) 0.050 0.050 0.049 0.049
Table 3.6: FWE of one-sided MCTs (ratios) for p = 5 treatments, the Dun-
nett contrast, several procedures and settings; µ = (100, 125, . . . , 125)′, θ =
(1.25, 1.25, 1.25, 1.25), α = 0.05.
Setting HOM GH PI HTL
a) 0.047 0.029 0.026 0.029
b) 0.006 0.032 0.026 0.022
c) 0.195 0.029 0.027 0.058
d) 0.029 0.028 0.028 0.028
Table 3.7: Local FWE of one-sided MCTs (ratios) for p = 3 treatments, the Dunnett
contrast, several procedures and settings; µ = (100, 1000, 125)′, θ = (1.25, 1.25)′,
α = 0.05.
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Setting HOM GH PI HTL
a) 0.064 0.045 0.040 0.041
b) 0.034 0.054 0.043 0.041
c) 0.147 0.048 0.043 0.052
d) 0.040 0.040 0.039 0.039
Table 3.8: Local FWE of one-sided MCTs (ratios) for p = 5 treatments, the
Dunnett contrast, several procedures and settings; µ = (100, 1000, 125, 125, 125)′,
θ = (1.25, 1.25, 1.25, 1.25), α = 0.05.
setting c) for the Tukey contrast (Table 3.1). HOM is absolutely liberal (0.211), GH
conservative (0.043), PI has an (almost) exact α-level (0.048), and HTL is liberal
(0.061). For a single simulation run (the same for all), there are df = 27 for HOM,
df ∗1 = 23.65, df ∗2 = 3.17, df ∗3 = 3.22 for GH and PI, and df ∗∗ = 10.01 for HTL. The
corresponding correlation matrices are
R =

1 0.34 −0.34
0.34 1 0.76
−0.34 0.76 1
 (HOM, GH),
R∗ =

1 0.11 −0.14
0.11 1 0.97
−0.14 0.97 1
 (PI),
R∗∗ =

1 0.31 0.31
0.31 1 0.31
0.31 0.31 1
 (HTL).
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The improvement of GH over HOM is obviously the use of several adjusted degrees
of freedom ν∗l according to Satterthwaite [1946]. However, the final step to handle
heteroscedasticity is to take the estimators of the variances S2h into account within
the correlations (3.7) and (3.13). They will be significantly corrected in this way; the
correlations in GH and PI clearly differ. Thus, an important conclusion is that an
adjustment of only the degrees of freedom is not sufficient. On the other hand, the
HTL procedure, taking averages of correlations and degrees of freedom, is generally
too rough. This becomes especially clear in the case of Tukey contrasts because also
negative correlations appear there.
Figure 3.3 gives a graphical explanation for the PI procedure. The joint distribution
of T1 and T2 is shown (gray dots) against the background of the simulations for the
Dunnett procedure for the case of differences with p = 3 groups. The two different
bivariate t-distributions are illustrated as contour plots, where the red lines belong
to T1, and the blue lines belong to T2. Realizations for (T1, T2) that lead to rejection
are marked by crosses, the remaining ones by small circles. The two related quantiles
are equal only for setting d), the homoscedastic and balanced case. Generally, they
are not equidistant.
According to these investigations, the PI procedure maintains the α-level exactly.
Negligible variations about the nominal α-level are due to the fact that the correla-
tions are estimated ones, but a serious violation does not occur. After these remarks,
it should be clear that the HOM procedure should be used only with utmost care
and cannot be recommended in the presence of heteroscedasticity. The development
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Figure 3.3: Distribution of the test statistics for the Dunnett contrast; µ1 = 100, µ2 =
100, µ3 = 100.
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of new procedures was a necessary consequence. Because PI has the best properties,
the following considerations refer only to PI.
3.4 Simultaneous Confidence Intervals
3.4.1 Definition
The acceptance region of a statistical test is defined as the set of sample values
for which H0 is accepted. Inversion of the acceptance region yields the (simulta-
neous)confidence set (CS or SCS, respectively). This is a set of parameter values
for which a fixed sample belongs to the acceptance region. The probability that
the (true) parameter value is covered by the confidence set for each component is
defined as (simultaneous) coverage probability (CP or SCP, respectively). If the test
has level α, then the confidence set has a CP of at least 1 − α. This is verified by
the following
Proof. The probability that a level-α test wrongly rejects H0 for a given sample and
a fixed parameter value is at most α. Hence, the probability that the test correctly
accepts H0 for that sample is at least 1−α. This is nothing but the probability that
the sample belongs to the acceptance region, which is equal to the probability that
the parameter value belongs to the confidence set (according to the definition).
Having a multivariate test problem, one is usually interested in projecting the confi-
58 CHAPTER 3. MCTS IN THE PRESENCE OF HETEROSCEDASTICITY
dence set onto the coordinate axes for an easier interpretation. The axes correspond
to the contrasts here. These projections are defined as simultaneous confidence in-
tervals (SCIs). However, an exact projecting might not always be possible. We
will encounter this problem later. Nevertheless, SCIs are a method to handle both
parameter estimation and parameter testing.
3.4.2 Differences of Means
Let ξ = (ξ1, . . . , ξq)′ be a point in the parameter space of η = (η1, . . . , ηq)′ and
let higher values of the data Xhj represent a better effect of the treatments. The
(1− α)100% confidence set for the statistical problem (3.1) is given by
C ((x, y)) =
{
ξ : Tl(ξl) ≤ tlq,1−α(νˆl, Rˆ), l = 1, . . . , q
}
=
{
ξ : ηˆlowerl ≤ ξl, l = 1, . . . , q
}
,
where the lower limits ηˆlowerl of the approximate (1−α)100% SCIs for η are defined
as
ηˆlowerl =
(
p∑
h=1
clhX¯h
)
− tlq,1−α(νˆl, Rˆ)
√√√√ p∑
h=1
c2lhS
2
h/nh
= c′lX¯ − tlq,1−α(νˆl, Rˆ)
√
c′lVˆ Mcl (l = 1, . . . , q).
These limits can be used for the statistical problem (3.1). For a specified level α,
we reject H0l for each contrast ηl with
ηˆlowerl > δl.
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For the two-sided case, we obtain
C ((x, y)) =
{
ξ : |Tl(ξl)| ≤ ttsq,1−α(νˆl, Rˆ), l = 1, . . . , q
}
=
{
ξ : ηˆlowerl ≤ ξl ≤ ηˆupperl , l = 1, . . . , q
}
and confidence limits
ηˆlowerl =
(
p∑
h=1
clhX¯h
)
− ttsq,1−α(νˆl, Rˆ)
√√√√ p∑
h=1
c2lhS
2
h/nh,
= c′lX¯ − ttsq,1−α(νˆl, Rˆ)
√
c′lVˆ Mcl (l = 1, . . . , q)
ηˆupperl =
(
p∑
h=1
clhX¯h
)
+ ttsq,1−α(νˆl, Rˆ)
√√√√ p∑
h=1
c2lhS
2
h/nh
= c′lX¯ + t
ts
q,1−α(νˆl, Rˆ)
√
c′lVˆ Mcl (l = 1, . . . , q).
For a specified level α, we reject H0l for each contrast ηl with
ηˆlowerl > δl or ηˆ
upper
l < δl.
Figure 3.4 shows the influence of heteroscedasticity on the two-sided (1 − α)100%
confidence set for differences of means with a Dunnett contrast based on a hypo-
thetical dataset with p = 3 treatments. The confidence set widens for increasing
variances, but it becomes widest for that contrast (η2) with the highest variance.
Hence, the resulting SCIs, despite being symmetric, do not have the same width.
3.4.3 Ratios of Means
Let ξ = (ξ1, . . . , ξq)′ be a point in the parameter space of γ = (γ1, . . . , γq)′. For the
case that higher values of the data, Xhj, represent a better effect of the treatments,
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Figure 3.4: Two-sided 95% confidence set for the Dunnett contrast of p = 3 treat-
ments; n1 = n2 = n3 = 10, µ = (100, 100, 100)′.
the (1− α)100% confidence set for the statistical problem (3.9) is given by
C ((x, y)) =
{
ξ : Tl(ξl) ≤ tlq,1−α(νˆl, Rˆ), l = 1, . . . , q
}
=
{
ξ : Alξ
2
l +Blξl + Cl ≤ 0, l = 1, . . . , q
}
,
where
Al =
(
p∑
h=1
dlhX¯h
)2
−
(
tlq,1−α(νˆl, Rˆ)
)2 p∑
h=1
d2lhS
2
h/nh
=
(
d′lX¯
)2 − (tlq,1−α(νˆl, Rˆ))2 d′lVˆ Mdl,
Bl = −2
((
p∑
h=1
clhX¯h
)(
p∑
h=1
dlhX¯h
)
−
(
tlq,1−α(νˆl, Rˆ)
)2 p∑
h=1
clhdlhS
2
h/nh
)
= −2
((
c′lX¯
) (
d′lX¯
)− (tlq,1−α(νˆl, Rˆ))2 c′lVˆ Mdl) ,
Cl =
(
p∑
h=1
clhX¯h
)2
−
(
tlq,1−α(νˆl, Rˆ)
)2 p∑
h=1
c2lhS
2
h/nh
=
(
c′lX¯
)2 − (tlq,1−α(νˆl, Rˆ))2 c′lVˆ Mcl. (3.15)
This approach is based on Fieller’s Theorem [Fieller, 1954]. In contrast to SCIs for
differences, the correlation matrix Rˆ depends here on the unknown ratios γl, say
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ρˆll′ = ρˆll′(γl, γl′). Dilba et al. [2006] have used a plug-in approach in the homoscedas-
tic case and have shown a very good performance as compared to other methods.
The same problem also arises for the degrees of freedom, i.e., νˆl = νˆl(γl). Now the
estimator
γˆl =
∑p
h=1 clhX¯h∑p
h=1 dlhX¯h
=
c′lX¯
d′lX¯
(l = 1, . . . , q),
has to be used in Equations (3.12) and (3.14) instead of θl. The lower limits of the
approximate (1− α)100% SCIs for (γ1, . . . , γq)′ are hence given by
γˆlowerl =
−Bl −
√
B2l − 4AlCl
2Al
(l = 1, . . . , q).
If Al > 0, then it can be shown that the solution is finite (see, e.g., Buonaccorsi and
Iyer [1984] for the homoscedastic case). The statistical problem (3.9) can be decided
as follows: For a specified level α, we reject H0l for each contrast γl with
γˆlowerl > θl.
For the two-sided case, we obtain
C ((x, y)) =
{
ξ : |Tl(ξl)| ≤ ttsq,1−α(νˆl, Rˆ), l = 1, . . . , q
}
=
{
ξ : Alξ
2
l +Blξl + Cl ≤ 0, l = 1, . . . , q
}
,
where the Al, Bl and Cl are defined as in (3.15) but with quantiles ttsq,1−α(νˆl, Rˆ)
instead of tlq,1−α(νˆl, Rˆ). The confidence limits are given by
γˆlowerl =
−Bl −
√
B2l − 4AlCl
2Al
(l = 1, . . . , q),
γˆupperl =
−Bl +
√
B2l − 4AlCl
2Al
(l = 1, . . . , q). (3.16)
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Figure 3.5: Two-sided 95% confidence set for the Dunnett contrast of p = 3 treat-
ments; n1 = n2 = n3 = 10, µ = (100, 125, 125)′.
For a specified level α, we reject H0l for each contrast γl with
γˆlowerl > θl or γˆ
upper
l < θl.
Figure 3.5 shows the influence of heteroscedasticity on the two-sided (1 − α)100%
confidence set for ratios of means with a Dunnett contrast based on a hypothetical
dataset with p = 3 treatments. As in the case of differences, the confidence set
widens for increasing variances, and it becomes widest for that contrast (γ2) with
the highest variance. The resulting SCIs do not have the same width. In contrast to
the case of differences, the confidence set and the SCIs are not symmetric in general,
regardless of heteroscedasticity.
The strict one-to-one relation between the test decisions of MCTs and SCIs that
holds in the case of differences of means does not hold in the case of ratios of means.
This is due to the additional use of the estimator γˆl instead of θl in the calculation
of the necessary quantiles. The conclusions of the α-simulations in 3.3.2 are not
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γ1 = γ2
Setting
0.5 1.0 1.5 2.0
a) 0.950 0.950 0.949 0.948
b) 0.952 0.948 0.950 0.951
c) 0.948 0.949 0.944 0.943
d) 0.947 0.951 0.951 0.951
Table 3.9: SCP of one-sided (upper) SCIs (ratios) for p = 3 treatments, the Dunnett
contrast and several settings and ratios γ1 = γ2; µ1 = 100, α = 0.05.
applicable for the related SCIs without caution. We have thus performed further
simulation studies to describe the behavior of SCIs related to the PI procedure. The
same background as in 3.3.2 has been used and the simultaneous coverage probability
(SCP) has been simulated. The nominal level is 0.95 for all studies. Table 3.9 (3.10)
shows the results of the first (second) study for ratio-based Dunnett SCIs with three
(five) treatments, with the underlying settings and depending on the ratios γ1 = γ2
(γ1 = . . . = γ4). Only for a few cases (0.942, setting c), Table 3.10), a little liberalism
is observed, but not a unique influence or trend (ranges from 0.942 to 0.952). In
principle, the expected value 0.95 is attained for all the settings. This reflects the
results of the α-simulations.
The reason for the possible discrepancy between test decisions according to MCTs
and related SCIs is shown in the Figures 3.6 and 3.7. The area covered by the SCIs
according to (3.16) (dashed lines) does not cover the confidence set completely. An
exact projection is not possible here because of the non-rectangular shape of the con-
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γ1 = . . . = γ4
Setting
0.5 1.0 1.5 2.0
a) 0.950 0.948 0.947 0.950
b) 0.952 0.952 0.950 0.951
c) 0.947 0.947 0.947 0.942
d) 0.942 0.951 0.951 0.947
Table 3.10: SCP of one-sided (upper) SCIs (ratios) for p = 5 treatments, the Dunnett
contrast and several settings and ratios γ1 = . . . = γ4; µ1 = 100, α = 0.05.
fidence set. This problem is independent of the issue of homo- or heteroscedasticity
(see Dilba et al. [2006] and Dilba [2005]).
3.5 Power Considerations
The testing problem (3.1) for differences of means is simplified here to the case of
equal thresholds, δl = δ for all l = 1, . . . , q. Let higher response values indicate
better treatment effects and let ∗ denote the greatest irrelevant difference to the
control mean which is to be detected. Define the set of indices I (∗) = {l : l > ∗} =
{l1, . . . , lm} (m = 1, . . . , q). All contrasts with l values greater than ∗ are relevant.
The probability to detect all relevant contrasts is defined as the complete (or all-
pairs) power. An (approximate) expression for the complete power of statistical
problem (3.1) is given by
P
{
Tl > t
l
q,1−α(νl,R)
∣∣∣∣ψl, σ21, . . . , σ2k ∀l ∈ I(∗)} .
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Figure 3.6: Two-sided 95% confidence set for the Dunnett contrast; n1 = n2 = n3 =
10, µ = (20, 100, 100)′, s1 = 10; s2 = 30; s3 = 50.
Figure 3.7: Two-sided 95% confidence set for the Dunnett contrast; n1 = n2 = n3 =
10, µ = (100, 20, 20)′, s1 = 100; s2 = 10; s3 = 10.
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The probability to detect at least one relevant contrast is defined as the minimal (or
any-pair) power. An (approximate) expression for the minimal power of statistical
problem (3.1) is given by
P
{
Tl > t
l
q,1−α(νl,R)
∣∣∣∣ψl, σ21, . . . , σ2k for at least one l ∈ I(∗)} .
As in the case of differences, the testing problem (3.9) for ratios of means is also
simplified here to the case that the thresholds are equal, θl = θ for all l = 1, . . . , q.
Let higher response values indicate better treatment effects and τ ∗ denot the greatest
irrelevant ratio to the control mean which is to be detected. Define the set of indices
I (τ ∗) = {l : τl > τ ∗} = {l1, . . . , lm} (m = 1, . . . , q). All ratios of contrasts with τl
values greater than τ ∗ are relevant. In the same manner as above, an (approximate)
expression for the complete power of statistical problem (3.9) is given by
P
{
Tl > t
l
q,1−α(νl,R)
∣∣∣∣ψl, σ21, . . . , σ2k ∀l ∈ I(τ ∗)} .
The (approximate) expression for the minimal power of statistical problem (3.1) is
given by
P
{
Tl > t
l
q,1−α(νl,R)
∣∣∣∣ψl, σ21, . . . , σ2k for at least one l ∈ I(τ ∗)} .
Because of heteroscedasticity, adjustments of the degrees of freedom and of the
correlations between the test statistics are necessary. This means that in fact the
quantiles tlq,1−α(νl,R) are random variables, because they depend on the sample
values. Therefore, the above probabilities are only approximate ones. On the other
hand, each test statistic Tl will be compared with its own quantile, which comes from
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Figure 3.8: Power comparison of one-sided HOM and PI (differences) for p = 3
treatments and the Dunnett contrast; µ1 = 100, α = 0.05.
a q-variate t-distribution with its own degree of freedom νl. We do not use a joint
q-variate t-distribution for the test statistics (3.2) and (3.10). Power calculations are
therefore not possible so far. Power comparison by simulation is possible, however.
The different α-levels of the HOM and the PI procedure do not permit a fair power
comparison, especially for situations where HOM does not maintain the FWE. Nev-
ertheless, power is an important dimension. The results of the α-simulations have
shown that in a homoscedastic situation all the methods achieve practically the
same value, namely the specified α-level. However, the resulting degrees of freedom
of the PI or GH procedure are clearly smaller than corresponding ones according to
HOM. This may lead to a slight loss in power and to expanded SCIs under the al-
ternative hypothesis. A simulation study has been performed with the balanced and
homoscedastic setting described in Section 3.3. In addition, a smaller sample size
of n = 5 was considered where the sample size n is the same in each group. Figure
3.8 (3.9) shows the results of a power comparison between the one-sided HOM and
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Figure 3.9: Power comparison of one-sided HOM and PI (differences) for p = 5
treatments and the Dunnett contrast; µ1 = 100, α = 0.05.
PI in the case of differences of means, the Dunnett procedure with p = 3 (p = 5)
treatments and α = 0.05. Figure 3.10 (3.11) shows the corresponding results for
the ratio problem with θ1 = . . . = θq = 1.25. The left graphics refer to the case
where the first p − 1 treatment means are fixed and the last treatment mean has
been changed so that the last contrast (l = q = p − 1) was variable. Minimal and
complete power coincide in this case. The middle (right) graphics show the minimal
(complete) power when all the non-control treatment means (h = 2, . . . , p) have been
changed simultaneously and in the same amount so that all contrasts l = 1, . . . , q
were variable. HOM and PI have the same α-level here and differ only by negligible
power amounts for n = 10. This difference increases for n = 5 because the relative
difference for the degrees of freedom between HOM and PI increases for decreasing
sample size.
In practice, it is hard to decide whether the data are homoscedastic or not. If not,
three scenarios are possible. If the smallest sample size matches (approximately)
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Figure 3.10: Power comparison of one-sided HOM and PI (ratios) for p = 3 treat-
ments and the Dunnett contrast; µ1 = 100, α = 0.05.
Figure 3.11: Power comparison of one-sided HOM and PI (ratios) for p = 5 treat-
ments and the Dunnett contrast; µ1 = 100, α = 0.05.
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the highest standard deviation, a wrongly assumed homoscedasticity causes overly
liberal test decisions. Here, the PI procedure is strongly preferable irrespective of
the possible loss in power. If the highest sample size matches (approximately) the
highest standard deviation, the HOM procedure may also become conservative in
spite of higher degrees of freedom. This has been even more obvious in further
simulations which are not shown here. In such cases, one can expect a bad power for
HOM. If the data have heterogeneous variances and balanced sample sizes, HOM
also causes liberal test decisions. Hence, the HOM procedure is the power-optimal
method if the group variances can be assumed equal. If the data are assumed to
have heterogeneous variances, there are no power-based arguments against the use
of the PI procedure.
3.6 Examples
3.6.1 Birth Weights in a Reprotoxicological Study
The following data of an in-vivo toxicological study are taken from Westfall [1997]
and are available from the R package multcomp [Hothorn et al., 2008]. The response
variable is the average post-birth weight of mice in the entire litter. Pregnant mice
were randomized into four groups. The compound, in three different doses (5, 50,
500) and a control (0), was administered during pregnancy. The litters were evalu-
ated for birth weights. The question to be answered is whether or not the specified
substance is able to cause a critical weight reduction. Here, the variance depends
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Dose Sample mean Sample variance Sample size
0 32.31 7.26 20
5 29.31 25.93 19
50 29.87 14.16 18
500 29.65 29.21 17
Table 3.11: Summary statistics for the average post-birth weights of the data set of
Westfall [1997].
on the dose effect (see Table 3.11).
The testing problem is hence to show for which doses a critical decrease in weight
can be seen in comparison with the control. Let the control group be denoted by
h = 0 and the doses by h = 1, 2, 3. Applying the contrast matrices
C =

c′1
c′2
c′3
 =

0 1 0 0
0 0 1 0
0 0 0 1
 ,
D =

d′1
d′2
d′3
 =

1 0 0 0
1 0 0 0
1 0 0 0

leads to the ratios of contrasts
γl =
µl
µ0
(l = 1, 2, 3).
The hypotheses to be tested are given by
H0l : γl ≥ θ (l = 1, 2, 3)
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Dose p-value Upper confidence limit
5 0.043 (0.044) 0.998 (0.998)
50 0.042 (0.105) 0.998 (1.017)
500 0.105 (0.082) 1.018 (1.012)
Table 3.12: p-values and upper confidence limits of the test for the average post-birth
weights of the data set of Westfall [1997].
with θ = 1. Table 3.12 gives (adjusted) p-values and upper limits for the related
approximate (1 − α)100% SCIs for the ratios to the control mean. The values
in parantheses are found from the HOM procedure (which assumes homogeneous
variances). The two lower doses, 5 and 50, significantly differ from the control.
This example clearly shows how misleading the conclusions may be if the variance
heterogeneity is not taken into account. The HOM procedure underestimates dose
50, and overestimates dose 500.
A question arising for the toxicologists here is if the highest dose can really be
non-toxic while the lower doses are toxic. Assuming an increasing trend in toxicity
over the doses would imply a decreasing trend for the measurements. Hence the
conclusions, especially those about dose 500, must be questioned. However, a pos-
sible objection is that the testing problem has been formulated as a proof of hazard
because the objective has been to point out toxicity. However, conclusions about
non-significant doses are not allowed in this context. Indeed, dose 500 is not shown
to be safe. Maybe a proof of safety would have been more appropriate here. The
question to be answered would then be if (and if yes which) doses do not cause a
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Dose p-value Lower confidence limit
5 0.7638 (0.7048) 0.8199 (0.8238)
50 0.4959 (0.5230) 0.8544 (0.8391)
500 0.6691 (0.6009) 0.8203 (0.8311)
Table 3.13: p-values and lower confidence limits of the test (proof of safety) for the
average post-birth weights of the data set of Westfall [1997].
critical decrease in weight in comparison with the control. For this purpose, let us
assume that a weight reduction by no more than 10% of the control can still be
regarded as safe. The new hypotheses to be tested are
H0l : γl ≤ θ (l = 1, 2, 3)
with θ = 0.9. The test direction is thus reversed now. Table 3.13 provides (adjusted)
p-values and lower limits for the related approximate (1−α)100% SCIs. The values
in parantheses are again found by applying the HOM procedure. None of the doses
can be shown to be safe. Their sample means are not larger than 90% of the control
mean. Although the procedures PI and HOM come to the same conclusions, one
can see that HOM produces too small p-values and confidence intervals for doses 5
and 500, and a too large p-value and confidence interval for dose 50.
3.6.2 Micronucleus Assay
Adler and Kliesch [1990] have published data from a micronucleus assay on hydro-
quinone using a negative control, four doses of hydroquinone and the positive control
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cyclophosphamide. The goal is to show whether or not the underlying substance is
able to induce chromosome damage or to interact with the mitioc spindle apparatus.
The number of micronuclei per animal and 2000 scored cells of male mice at 24 h
sampling time are given. The variance of the data tends to increase with increasing
effects (see Table 3.14). The data are available from the R package mratios [Dilba
et al., 2008, 2007].
There is an ongoing debate about the definition of clinically relevant non-inferiority
margins (e.g., CPM [1999] and Lange and Freitag [2005]). A common non-inferiority
trial design involves the experimental drug, a reference drug or active control, and
a placebo control. For such three arm “gold standard” trials, Pigeot et al. [2003]
have proposed to formulate non-inferiority as a fraction of the trial sensitivity. This
results in hypotheses based on the ratio of differences of means. For a specified
threshold θ, the alternative hypothesis indicates that the relative efficacy of the
experimental drug is more than θ ∗ 100% of the efficacy of the reference compound
as compared to placebo. For this ratio hypothesis, a t-distributed test statistic
has been derived, assuming variance homogeneity. However, it is quite common to
observe heteroscedasticity in such three-arm trials.
Non-inferiority tests can also be used as proofs of safety in toxicological experiments,
where the difference between a dose group and a vehicle control is considered in
relation to the difference between the positive control and the vehicle (see Hauschke
et al. [2005]). The mutagenicity data set of Adler and Kliesch [1990] (refer to Table
3.14) has already been evaluated in the sense of a proof of safety by Hauschke et al.
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Treatment group Sample mean Sample standard deviation Sample size
Vehicle control 2.57 1.27 7
30 mg/kg 3.80 1.10 5
50 mg/kg 6.20 1.48 5
75 mg/kg 14.0 3.94 5
100 mg/kg 20.0 4.06 5
Positive control 25.0 8.91 4
Table 3.14: Summary statistics for the number of micronuclei per animal and 2000
scored cells of the mutagenicity data set of Adler and Kliesch [1990].
[2005] and Hasler et al. [2008]. The concept of the maximal safe dose according to
Hothorn and Hauschke [2000] is used, i.e., the identification of the highest dose that
is non-inferior to the vehicle control, and all lower doses are non-inferior, too. Since
increasing numbers of micronuclei are unsafe, the 95% one-sided upper confidence
limits have been used. The authors applied the three-arm trial approach. Confidence
intervals for the difference between the dose groups and the vehicle control relative to
the difference between a positive control and the vehicle control have been calculated
with a safety threshold θ = 0.5. Hauschke et al. [2005] have assumed approximate
normal distribution and variance homogeneity, Hasler et al. [2008] have allowed for
heterogeneity. All their limits are marginal.
When not considering the maximal safe dose and interest is just in simultaneously
comparing the doses in sense of three-arm trials, multiplicity adjustment is necessary.
In terms of both three-arm trials and MCTs, let the vehicle control be considered
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as the placebo (h = 0), the doses as experimental treatments (h = 1, . . . , 4) and the
positive control as reference (h = 5). Application of the contrast matrices
C =

c′1
c′2
c′3
c′4

=

−1 1 0 0 0 0
−1 0 1 0 0 0
−1 0 0 1 0 0
−1 0 0 0 1 0

,
D =

d′1
d′2
d′3
d′4

=

−1 0 0 0 0 1
−1 0 0 0 0 1
−1 0 0 0 0 1
−1 0 0 0 0 1

leads to the ratios of contrasts
γl =
µl − µ0
µ5 − µ0 (l = 1, . . . , 4).
The hypotheses to be tested are given by
H0l : γl ≥ θ (l = 1, . . . , 4)
Treatment group p-value Upper confidence limit
30 mg/kg 0.0225 (0.0002) 0.16 (0.28)
50 mg/kg 0.0472 (0.0032) 0.36 (0.38)
75 mg/kg 0.7275 (0.8786) 1.17 (0.75)
100 mg/kg 0.9906 (1.0000) 2.05 (1.06)
Table 3.15: p-values and upper confidence limits of the tests for the micronucleus
assay data of Adler and Kliesch [1990].
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with θ = 0.5. Table 3.15 shows (adjusted) p-values and upper limits for the related
approximate (1 − α)100% SCIs. The p-values and the limits according to HOM
are given in parentheses. The two lower doses, 30 mg/kg and 50 mg/kg, show
an acceptable increase; the two higher doses, 75 mg/kg and 100 mg/kg, do not.
Although the decisions about the doses are the same for PI and HOM, it is interesting
to see that the p-values and the upper limits are markedly different.
Chapter 4
Multiple Contrast Tests for Multiple
Endpoints
4.1 Introduction
Experimental trials often do not cover only one single endpoint but many (see the
data of Schulte et al. [2002] in Section 4.7). A measurement object may be related
to different variables or be observed in the course of time. Multiplicity adjustment
must then take the number of endpoints into account, too. Thus, the first strategy is
to reduce the number of endpoints to the smallest possible number that is necessary
and that still provides the main information about the data. Second, it is useful to
divide the endpoints into primary and secondary ones, where the primary endpoints
are most important. The guideline on biostatistics according to the ICH E9 Expert
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Working Group [1999] recommends the selection of one primary endpoint. However,
this is often not sufficient from an investigator’s point of view. The secondary end-
points are considered only after the primary objective of the trial has been achieved.
A possible objection is that such a classification of endpoints according to their im-
portance can be somewhat arbitrary. Like the first, this strategy also reduces the
dimension of the problem, but the question, how to handle multiple primary end-
points, remains. The statistical analysis for these endpoints must control the FWE
over all of them. On the other hand, their correlations are important. For example,
highly correlated endpoints do not give the same amount of information about the
data as uncorrelated ones. Effects may be erroneously ignored when analyzing the
endpoints separately.
Neuhäuser [2006] gives a comprehensive review of statistical methods with focus on
two-armed trials. A Bonferroni adjustment for the local test on each endpoint is a
simple solution of the abovementioned problem. The information about correlations
is disregarded in this case. As is known, this technique yields conservative test deci-
sions and intervals, especially for large numbers of endpoints (see Section 2.5). The
stepwise procedure of Holm [1979] is more powerful. The procedures of Hochberg
[1988] and Hommel [1988] are yet more powerful than Holm’s, but the assumption
of independence of the p-values must be fulfilled. A drawback is also the fact that
no (meaningful) SCIs are available. Gatekeeping procedures avoid multiplicity ad-
justment by proceeding hierarchically. When multiple hypotheses are to be tested
in a prespecified order according to their relevance, multiplicity adjustment is not
necessary. As long as the local null hypotheses of the prior endpoints have been
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rejected, each local null hypothesis can be tested in a preassigned order at level α
[Bauer, 1991]. The procedure stops if a p-value is larger than α. Dmitrienko et al.
[2003] have developed parallel gatekeeping strategies that require only one primary
effect to be significant for proceeding. Unfortunately, this method also needs an ex-
tra (e.g., Bonferroni) internal adjustment, and (meaningful) SCIs are not available.
Only if resampling-based tests are used, the authors exploit the endpoint’s corre-
lations. The T 2 test of Hotelling [1951] also takes correlations into account, but
because of a square sum test statistic it is non-directional and hence not meaningful
in many application areas. Furthermore, the test conclusions are merely global ones
in the sense that they cannot be attributed to single endpoints. Stabilized alterna-
tives to the T 2 test, using linear scores (see Kropf et al. [1997] for example), suffer
from similar drawbacks.
For the sake of completeness, it should be mentioned that the above methods claim
a treatment effect if there is a significant difference for at least one endpoint, i.e.,
they are UITs. If significant differences are necessary for all endpoints to claim a
treatment effect, an IUT can be applied (see Section 2.1). The local tests for the
endpoints do not need a multiplicity adjustment. They can be performed with level
α. Then test decisions are only global; conclusions about single endpoints are not
allowed if the global test does not reject. For this reason, the following considerations
will not concern IUTs.
MCTs and related SCIs provide test decisions and parameter estimation, respec-
tively, for each comparison. They control the FWE at level α, and take correlations
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into account. However, they are limited to comparisons of treatments on a single
endpoint so far. This work presents an extension of MCTs and SCIs for multiple
endpoints. We focus on ratios of means, because SCIs are then comparable also for
the different endpoints, which can be assumed to have different scales.
In Section 4.2, the testing problem is formulated and an approximate distribution for
the test statistics is derived. Section 4.3 shows results of α-simulations for several
contrasts and correlations of endpoints. SCIs are considered in Section 4.4, the
heteroscedastic case in Section 4.6. We give an example in Section 4.7.
4.2 Test Procedure
For h = 1, . . . , p, i = 1, . . . , k and j = 1, . . . , nh, let Xhij denote the jth ob-
servation on the ith endpoint under the hth treatment in a one-way layout, and∑p
h=1(nh − 1) ≥ k. Each endpoint is hence measured for all N =
∑p
h=1 nh objects.
Suppose the random variables Xhij to be mutually independent and follow k-variate
normal distributions with mean vectors µh = (µh1, . . . µhk)′ and unknown covariance
matrices Σh = (σh,ii′)i,i′ . Let the means per endpoint, µ1i, . . . , µpi, have the same
algebraic sign, i.e., sign(µ1i) = . . . = sign(µpi) (i = 1, . . . , k). Presume possibly dif-
ferent variances and covariances for the endpoints but the same covariance matrices
for all treatments, i.e., Σ1 = . . . = Σp = Σ = (σii′)i,i′ . That means
{Xhij : i = 1, . . . , k} ∼ ⊥Nk(µh,Σ) (h = 1, . . . , p, j = 1, . . . , nh).
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Let X¯h = (X¯h1, . . . , X¯hk)′ and Σˆh be the sample mean vectors and the sample
covariance matrices for the treatments, respectively, with
X¯hi =
1
nh
nh∑
j=1
Xhij (h = 1, . . . , p).
The pooled sample covariance matrix Σˆ = (σˆii′)i,i′ is given by
Σˆ =
∑p
h=1(nh − 1)Σˆh∑p
h=1(nh − 1)
with the estimates σˆii′ (1 ≤ i, i′ ≤ k) for the covariances of the different endpoints.
The diagonal elements, which are required for the following test procedure, are hence
σˆii = S
2
i =
(n1 − 1)S21i + · · ·+ (np − 1)S2pi
n1 + · · ·+ np − p (i = 1, . . . , k)
with
S2hi =
1
nh − 1
nh∑
j=1
(Xhij − X¯hi)2 (h = 1, . . . , p).
From the pooled sample covariance matrix Σˆ, we then derive the estimation Rˆ =
(ρˆii′)i,i′ of the common correlation matrix of the dataR = (ρii′)i,i′ . We are interested
in the matrix of ratios of contrasts, G = (γli)l,i, where
γli =
∑p
h=1 clhµhi∑p
h=1 dlhµhi
=
c′lµ,i
d′lµ,i
(l = 1, . . . , q, i = 1, . . . , k)
with µ,i = (µ1i, . . . , µpi)′. The vectors cl = (cl1, . . . , clp)′ and dl = (dl1, . . . , dlp)′
consist of real constants and are the same for all endpoints; they do not depend on
the particular value of the index i. Endpoint-specific contrasts are also possible in
principle, but we disregard this fact for simplicity. Without loss of generality, the
objective is to test the hypotheses
H0,li : γli ≤ θli (l = 1, . . . , q, i = 1, . . . , k) (4.1)
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with contrast- and endpoint-specific relative thresholds θli ∈ (0,∞). Usually, θli = 1
for all l = 1, . . . , q and for all i = 1, . . . , k. If the test direction is reversed for
some endpoints, the corresponding test statistics have to be multiplied with minus
one. We focus here on ratios of means to enable comparison of the results for the
different endpoints, which can be assumed to have different scales. Related SCIs for
ratios are on the same relative (e.g., per cent) scale for all contrasts and endpoints,
while SCIs for differences are not. On the other hand, for the case of θli = 1 for all
l = 1, . . . , q and for all i = 1, . . . , k, this test coincides with the difference-based one.
Testing problem (4.1) is a UIT because the overall null hypothesis of interest can be
expressed as an intersection of the local null hypotheses, i.e.,
H0 =
q⋂
l=1
H0l and H0l =
k⋂
i=1
H0,li.
Thus, Theorem 2.1.3 holds and the procedure is coherent and consonant. We reshape
(4.1) and set
ψli =
p∑
h=1
clhµhi − θli
p∑
h=1
dlhµhi =
p∑
h=1
(clh − θlidlh)µhi
= (cl − θlidl)′µ,i (l = 1, . . . , q, i = 1, . . . , k)
with estimator
ψˆli =
p∑
h=1
(clh − θlidlh) X¯hi
= (cl − θlidl)′ X¯ ,i (l = 1, . . . , q, i = 1, . . . , k)
and X¯ ,i = (X¯1i, . . . , X¯pi)′. Since
V ar(ψˆli) =
p∑
h=1
(clh − θlidlh)2 σii/nh
= σii (cl − θlidl)′M (cl − θlidl) (l = 1, . . . , q, i = 1, . . . , k),
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we obtain the test statistics
Tli =
∑p
h=1 (clh − θlidlh) X¯hi
Si
√∑p
h=1 (clh − θlidlh)2 /nh
=
(cl − θlidl)′ X¯ ,i
Si
√
(cl − θlidl)′M (cl − θlidl)
(l = 1, . . . , q, i = 1, . . . , k)
where
M =

1/n1 0
. . .
0 1/np
 .
The vectors T l = (Tl1, . . . , Tlk)′, containing the test statistics for the lth comparison
on all endpoints, can be reshaped to
T l =
(
Yl1√
U1/ν
, . . . ,
Ylk√
Uk/ν
)′
(l = 1, . . . , q),
where under H0l, the vector (Yl1, . . . , Ylk)′ follows a k-variate normal distribution
with a correlation matrix denoted byRll. The U1, . . . , Uk are dependent χ2 variables
with
ν =
p∑
h=1
(nh − 1)
degrees of freedom. Note that U1, . . . , Uk are different random variables but they
follow the same distribution. Therefore, under H0l, T l is approximately k-variate
t-distributed with ν degrees of freedom and correlation matrix Rll, i.e.,
T l
appr.∼ tk(ν,Rll).
This is in fact a possible definition of a multivariate t-variable (see, e.g., Tong [1990],
page 202f), though not the classical one. Moreover, under H0, the vector of all test
statistics,
T = (T ′1, . . . ,T
′
q)
′ = (T11, . . . , Tli, . . . , Tqk)′,
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follows (approximately) a qk-variate t-distribution with ν degrees of freedom and a
correlation matrix, denoted by R˜, i.e.,
T
appr.∼ tqk(ν, R˜).
The correlation matrix R˜ is given by
R˜ = (Rll′)l,l′ =

R11 R12 . . . R1q
R12 R22 . . . R2q
...
... . . .
...
R1q R2q . . . Rqq

.
The submatrices Rll′ = (ρll′,ii′)i,i′ describe the correlations between the contrasts l
and l′ for all endpoints. In order to calculate their elements, let us evaluate the
correlation between
∑p
h=1 (clh − θlidlh) X¯hi and
∑p
h=1 (cl′h − θl′i′dl′h) X¯hi′ :
Cov
(
p∑
h=1
(clh − θlidlh) X¯hi,
p∑
h=1
(cl′h − θl′i′dl′h) X¯hi′
)
= E
[(
p∑
h=1
(clh − θlidlh) X¯hi − E
(
p∑
h=1
(clh − θlidlh) X¯hi
))
(
p∑
h=1
(cl′h − θl′i′dl′h) X¯hi′ − E
(
p∑
h=1
(cl′h − θl′i′dl′h) X¯hi′
))]
= E
[(
p∑
h=1
(clh − θlidlh)
(
X¯hi − EX¯hi
))( p∑
h=1
(cl′h − θl′i′dl′h)
(
X¯hi′ − EX¯hi′
))]
= E
[
p∑
h=1
p∑
h′=1
(clh − θlidlh) (cl′h′ − θl′i′dl′h′)
(
X¯hi − EX¯hi
) (
X¯h′i′ − EX¯h′i′
)]
=
p∑
h=1
(clh − θlidlh) (cl′h − θl′i′dl′h)E
((
X¯hi − EX¯hi
) (
X¯hi′ − EX¯hi′
))
+
p∑
h=1
p∑
h′=1,h′ 6=h
(clh − θlidlh) (cl′h′ − θl′i′dl′h′)E
((
X¯hi − EX¯hi
) (
X¯h′i′ − EX¯h′i′
))
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=
p∑
h=1
(clh − θlidlh) (cl′h − θl′i′dl′h)Cov
(
X¯hi, X¯hi′
)
+
p∑
h=1
(clh − θlidlh)E
(
X¯hi − EX¯hi
) p∑
h′=1,h′ 6=h
(cl′h′ − θl′i′dl′h′)E
(
X¯h′i′ − EX¯h′i′
)
=
p∑
h=1
(clh − θlidlh) (clh − θli′dlh)Cov
(
X¯hi, X¯hi′
)
+
p∑
h=1
(clh − θlidlh)
(
EX¯hi − EX¯hi
) p∑
h′=1,h′ 6=h
(cl′h′ − θl′i′dl′h′)
(
EX¯h′i′ − EX¯h′i′
)
=
p∑
h=1
(clh − θlidlh) (cl′h − θl′i′dl′h)Cov
(
X¯hi, X¯hi′
)
.
Obviously,
Cov(X¯hi, X¯hi′)
= E
(
(X¯hi − µhi)(X¯hi′ − µhi′)
)
= E
((
1
nh
nh∑
j=1
Xhij
)
−
(
1
nh
nh∑
j=1
µhi
))((
1
nh
nh∑
j′=1
Xhi′j′
)
−
(
1
nh
nh∑
j′=1
µhi′
))
= E
(
1
nh
nh∑
j=1
(Xhij − µhi) 1
nh
nh∑
j′=1
(Xhi′j′ − µhi′)
)
=
1
n2h
E
(
nh∑
j=1
nh∑
j′=1
(Xhij − µhi)(Xhi′j′ − µhi′)
)
=
1
n2h
(
nh∑
j=1
nh∑
j′=1
Cov(Xhij, Xhi′j′)
)
.
Because all measurements j 6= j′ are independent, their covariances vanish, so that
we may write
Cov(X¯hi, X¯hi′) =
1
nh
Cov(Xhi, Xhi′).
Hence, it follows that
ρll′,ii′ = Corr
(
p∑
h=1
(clh − θlidlh) X¯hi,
p∑
h=1
(cl′h − θl′i′dl′h) X¯hi′
)
=
∑p
h=1 (clh − θlidlh) (cl′h − θl′i′dl′h) 1nhCov(Xhi, Xhi′)√
V ar
(∑p
h=1 (clh − θlidlh) X¯hi
)√
V ar
(∑p
h=1 (cl′h − θl′i′dl′h) X¯hi′
)
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=
∑p
h=1 (clh − θlidlh) (cl′h − θl′i′dl′h) 1nhσii′√∑p
h=1 (clh − θlidlh)2 V arX¯hi
√∑p
h=1 (cl′h − θl′i′dl′h)2 V arX¯hi′
=
σii′
∑p
h=1 (clh − θlidlh) (cl′h − θl′i′dl′h) 1nh√∑p
h=1 (clh − θlidlh)2 1nhσii
√∑p
h=1 (cl′h − θl′i′dl′h)2 1nhσi′i′
and finally
ρll′,ii′ = ρii′
∑p
h=1 (clh − θlidlh) (cl′h − θl′i′dl′h) 1nh√∑p
h=1 (clh − θlidlh)2 1nh
√∑p
h=1 (cl′h − θl′i′dl′h)2 1nh
(4.2)
= ρii′
(cl − θlidl)′M (cl′ − θl′i′dl′)√
(cl − θlidl)′M (cl − θlidl)
√
(cl′ − θl′i′dl′)′M (cl′ − θl′i′dl′)
(1 ≤ l, l′ ≤ q, 1 ≤ i, i′ ≤ k),
where the ρii′ are the elements of the correlation matrix R = (ρii′)i,i′ of the data.
It is obvious that for i = i′, we recover the correlations of an MCT for ratios of
means, see, e.g., Dilba et al. [2006]. Hence, the case of only one endpoint (k = 1)
and several treatments may be incorporated into the present theory rather easily.
Furthermore, focusing on one fixed contrast (l = l′) and equal thresholds for all
endpoints (θli = θl ∀ i = 1, . . . , k), the structure of the correlation matrix simplifies
according to ρll′,ii′ = ρii′ and Rll = R. Note that neither the matrix R˜ nor the
matrix Rll′ has a product correlation structure, i.e., the elements do not factorize.
Because the common correlation matrix of the data R is not known and must be
estimated, we conclude that, under H0,
T
appr.∼ tqk(ν, ˆ˜R),
where ˆ˜R is the estimation of R˜.
Example 4.2.1. Let there be observations for p = 3 groups and k = 3 endpoints
with equal sample sizes, being mutually independent and following k-variate normal
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distributions with homogeneous covariance matrices. Let the common correlation
matrix of the data be given by
R =

1 −0.2 0.5
−0.2 1 0.1
0.5 0.1 1
 .
The Dunnett MCT is applied (where the first group is regarded as the negative
control). The thresholds are all equal, i.e., θli = 1 for all l = 1, . . . , q and for all
i = 1, . . . , k. The resulting correlation matrix R˜ is given by
R˜ =
 R11 R12
R12 R22
 =

1 −0.2 0.5 0.5 −0.1 0.25
−0.2 1 0.1 −0.1 0.5 0.05
0.5 0.1 1 0.25 0.05 0.5
0.5 −0.1 0.25 1 −0.2 0.5
−0.1 0.5 0.05 −0.2 1 0.1
0.25 0.05 0.5 0.5 0.1 1

.
The (3× 3)-submatrices on the main diagonal are equal to the correlation matrix of
the data, i.e., R11 = R22 = R.
Example 4.2.2. Consider the situation of the Example 4.2.1, where we now apply
the Williams MCT. The resulting correlation matrix R˜ is then given by
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R˜ =
 R11 R12
R12 R22
 =

1 −0.2 0.5 0.87 −0.17 0.43
−0.2 1 0.1 −0.17 0.87 0.09
0.5 0.1 1 0.43 0.09 0.87
0.87 −0.17 0.43 1 −0.2 0.5
−0.17 0.87 0.09 −0.2 1 0.1
0.43 0.09 0.87 0.5 0.1 1

.
As in Example 4.2.1, the (3× 3)-submatrices on the main diagonal are equal to the
correlation matrix of the data. The off-diagonal submatrices R12 differ from those
of Example 4.2.1, of course.
The decision rule for testing problem (4.1) is to reject H0,li for each ratio of contrasts
γli with
Tli > t
l
qk,1−α(ν,
ˆ˜R),
where tlqk,1−α(ν,
ˆ˜R) is a lower (1−α)-quantile of a related qk-variate t-distribution. If
two-sided testing is of interest, the absolute values for Tli and quantiles ttsqk,1−α(ν,
ˆ˜R)
have to be taken. For the computation of these quantiles, one may resort to the
numerical integration routines of Genz and Bretz [1999, 2002] (see also Bretz et al.
[2001]) mentioned earlier, which are not restricted to special correlation structures.
The related adjusted p-values per comparison and endpoint can also be obtained, of
course.
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4.3 α-simulations
As in Chapter 3, the method described in Section 4.2 is approximate. Hence, its
quality must be validated by simulations. Three treatments have been compared in
a first simulation study, five in a second one. The first treatment is regarded as the
(negative) control. Dunnett and Williams contrasts, related to the hypotheses (4.1),
have been considered. Each study had different numbers of endpoints with related
expected values for the control group, i.e.,
• 2 endpoints, µ1 = (10, 100),
• 4 endpoints, µ1 = (0.1, 1, 10, 100),
• 8 endpoints, µ1 = (0.05, 0.1, 0.5, 1, 5, 10, 50, 100).
For the Dunnett contrast, the expected values of the non-control groups are µh =
(0.8µ1,1, . . . , 0.8µ1,k/2, 1.25µ1,k/2+1, . . . , 1.25µ1,k)
′ (h = 2, . . . , p), and µh = µ1 (h =
2, . . . , p) for the Williams contrast. The endpoints have equicorrelations ρmin (see
(2.3)), 0, 0.5, 1. The standard deviations are 0.25µ1 for all treatments. The sample
size is 20 for each endpoint of each treatment. The FWE has been simulated at
a nominal level of 0.05. The simulation results have been obtained from 10000
simulation runs each and with the same starting seed (seed 10000) using a program
code in the statistical software R [2008], package mvtnorm [Genz et al., 2008, Hothorn
et al., 2001].
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Table 4.1 (4.2) shows results of the first (second) study with three (five) treatments.
The values in parentheses are according to a Bonferroni adjustment, which is known
to produce conservative test decisions, especially for high correlations (see Section
2.5). The new procedure maintains the α-level exactly (ranges from 0.045 to 0.054)
while the Bonferroni-adjusted version becomes more and more conservative for in-
creasing correlations and increasing number of endpoints.
In order to appreciate the strong control of the FWE, we have again treated the
situation of the Dunnett contrast. Let all non-control treatments significantly differ
from the control for the first endpoint, i.e., µh,1 = 10 ∗ µ1,1 (h = 2, . . . , p). Only the
FWE of the remaining comparisons has been considered. Tables 4.3 and 4.4 show the
α-level of the new procedure ignoring the first endpoint. Depending on the number
of these comparisons, the FWE is smaller then the α-level. The Bonferroni-adjusted
version is conservative in the same manner as above.
4.4 Simultaneous Confidence Intervals
Let ξ = (ξ11, . . . , ξqk)′ be a point in the parameter space of γ = (γ11, . . . , γqk)′.
Assuming that increasing values of the data, Xhij, represent a better effect of the
treatments, the (1− α)100% confidence set for the statistical problem (4.1) is given
by
C ((x, y)) =
{
ξ : Tli(ξli) ≤ tlqk,1−α(ν, ˆ˜R), l = 1, . . . , q, i = 1, . . . , k
}
=
{
ξ : Aliξ
2
li +Bliξli + Cli ≤ 0, l = 1, . . . , q, i = 1, . . . , k
}
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Correlations
MCT Endpoints
ρmin 0 0.5 1
0.049 0.051 0.053 0.046
2
(0.046) (0.046) (0.045) (0.026)
0.047 0.050 0.048 0.051
Dunnett 4
(0.044) (0.046) (0.036) (0.015)
0.047 0.046 0.052 0.051
8
(0.043) (0.042) (0.036) (0.009)
0.049 0.052 0.049 0.052
2
(0.036) (0.038) (0.033) (0.021)
0.050 0.048 0.051 0.045
Williams 4
(0.037) (0.035) (0.030) (0.009
0.048 0.048 0.054 0.049
8
(0.037) (0.035) (0.029) (0.006)
Table 4.1: FWE of one-sided MCTs for p = 3 treatments, several contrasts, numbers
of endpoints, and equicorrelations; α = 0.05; values in parentheses according to
Bonferroni adjustment.
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Correlations
MCT Endpoints
ρmin 0 0.5 1
0.051 0.052 0.052 0.052
2
(0.043) (0.045) (0.040) (0.028)
0.052 0.053 0.052 0.049
Dunnett 4
(0.045) (0.046) (0.038) (0.013)
0.049 0.051 0.050 0.050
8
(0.043) (0.044) (0.036) (0.008)
0.050 0.050 0.053 0.052
2
(0.025) (0.024) (0.023) (0.014)
0.050 0.054 0.048 0.051
Williams 4
(0.028) (0.029) (0.024) (0.007)
0.049 0.052 0.048 0.049
8
(0.027) (0.027) (0.021) (0.004)
Table 4.2: FWE of one-sided MCTs for p = 5 treatments, several contrasts, numbers
of endpoints, and equicorrelations; α = 0.05; values in parentheses according to
Bonferroni adjustment.
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Correlations
Endpoints
ρmin 0 0.5 1
0.023 0.027 0.027 0.037
2
(0.022) (0.025) (0.023) (0.019)
0.035 0.037 0.044 0.045
4
(0.033) (0.033) (0.034) (0.013)
0.041 0.041 0.048 0.051
8
(0.038) (0.037) (0.033) (0.009)
Table 4.3: Local FWE of one-sided MCTs for p = 3 treatments, the Dunnett contrast,
several numbers of endpoints, and equicorrelations; α = 0.05; values in parantheses
according to Bonferroni adjustment.
Correlations
Endpoints
ρmin 0 0.5 1
0.024 0.022 0.025 0.039
2
(0.021) (0.018) (0.020) (0.018)
0.037 0.038 0.040 0.049
4
(0.032) (0.033) (0.030) (0.013)
0.043 0.045 0.044 0.050
8
(0.037) (0.039) (0.032) (0.008)
Table 4.4: Local FWE of one-sided MCTs for p = 5 treatments, the Dunnett contrast,
several numbers of endpoints, and equicorrelations; α = 0.05; values in parantheses
according to Bonferroni adjustment.
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where
Ali =
(
p∑
h=1
dlhX¯hi
)2
−
(
tlqk,1−α(ν,
ˆ˜R)
)2
S2i
p∑
h=1
d2lh/nh
=
(
d′lX¯ ,i
)2 − (tlqk,1−α(ν, ˆ˜R))2 S2i d′lMdl,
Bli = −2
((
p∑
h=1
clhX¯hi
)(
p∑
h=1
dlhX¯hi
)
−
(
tlqk,1−α(ν,
ˆ˜R)
)2
S2i
p∑
h=1
clhdlh/nh
)
= −2
((
c′lX¯ ,i
) (
d′lX¯ ,i
)− (tlqk,1−α(ν, ˆ˜R))2 S2i c′lMdl) ,
Cli =
(
p∑
h=1
clhX¯hi
)2
−
(
tlqk,1−α(ν,
ˆ˜R)
)2
S2i
p∑
h=1
c2lh/nh
=
(
c′lX¯ ,i
)2 − (tlqk,1−α(ν, ˆ˜R))2 S2i c′lMcl. (4.3)
As in Section 3.4.3, this approach is based on Fieller’s Theorem [Fieller, 1954].
As is known, the correlation matrix R˜ depends here on the unknown ratios γli,
ρˆll′,ii′ = ρˆll′,ii′(γli, γl′i′). Application of the plug-in approach of Dilba et al. [2006]
corresponds to the use of
γˆli =
∑p
h=1 clhX¯hi∑p
h=1 dlhX¯hi
=
c′lX¯ ,i
d′lX¯ ,i
(l = 1, . . . , q, i = 1, . . . , k)
in Equation (4.2) instead of θli (similarly for index l′i′). For simplicity, we do not
introduce a new symbol for the resulting estimated correlation matrix. The lower
limits of the approximate (1− α)100% SCIs for (γ11, . . . , γqk)′ are hence given by
γˆlowerli =
−Bli −
√
B2li − 4AliCli
2Ali
(l = 1, . . . , q, i = 1, . . . , k).
If Ali > 0, then the solution is finite (see, e.g., Buonaccorsi and Iyer [1984] for the
case of only one endpoint). The statistical problem (4.1) can be decided as follows:
For a specified level α, we reject H0,li for each contrast γli with
γˆlowerli > θli.
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For the two-sided case, we obtain
C ((x, y)) =
{
ξ : |Tli(ξli)| ≤ ttsqk,1−α(ν, ˆ˜R), l = 1, . . . , q, i = 1, . . . , k
}
=
{
ξ : Aliξ
2
li +Bliξli + Cli ≤ 0, l = 1, . . . , q, i = 1, . . . , k
}
,
where the Ali, Bli and Cli are defined as in (4.3) but with quantiles ttsqk,1−α(ν,
ˆ˜R)
instead of tlqk,1−α(ν,
ˆ˜R). The confidence limits are given by
γˆlowerli =
−Bli −
√
B2li − 4AliCli
2Ali
(l = 1, . . . , q, i = 1, . . . , k),
γˆupperli =
−Bli +
√
B2li − 4AliCli
2Ali
(l = 1, . . . , q, i = 1, . . . , k).
For a specified level α, we reject H0,li for each contrast γli with
γˆlowerli > θli or γˆ
upper
li < θli.
We have performed further simulation studies with the same background as in 4.3
to describe the behavior of SCIs related to the new procedure. The SCP has been
simulated for the Dunnett contrast with a nominal level of 0.95. Table 4.5 (4.6)
shows the results of the first (second) study for ratio-based Dunnett SCIs with three
(five) treatments for different numbers of endpoints and depending on the ratios
γ = γ11 = . . . = γ2k (γ = γ11 = . . . = γ4k). In principle, the expected value
0.95 is again attained for all the settings irrespective of the number of endpoints,
treatments, and the correlations (ranges from 0.943 to 0.954). This reflects the
results of the α-simulations.
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Correlations
Endpoints γ
ρmin 0 0.5 1
0.5 0.946 0.946 0.949 0.950
1.0 0.948 0.949 0.949 0.950
2
1.5 0.950 0.947 0.948 0.948
2.0 0.949 0.954 0.950 0.946
0.5 0.949 0.952 0.949 0.949
1.0 0.950 0.947 0.950 0.949
4
1.5 0.948 0.950 0.948 0.952
2.0 0.948 0.950 0.947 0.949
0.5 0.950 0.950 0.950 0.949
1.0 0.950 0.949 0.947 0.950
8
1.5 0.954 0.949 0.948 0.946
2.0 0.949 0.947 0.946 0.951
Table 4.5: SCP of one-sided (upper) SCIs for p = 3 treatments, the Dunnett contrast,
several numbers of endpoints, ratios γli = γ (for all l = 1, 2 and i = 1, . . . , k), and
equicorrelations; α = 0.05.
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Correlations
Endpoints γ
ρmin 0 0.5 1
0.5 0.949 0.948 0.947 0.951
1.0 0.952 0.948 0.945 0.948
2
1.5 0.954 0.947 0.947 0.950
2.0 0.953 0.948 0.946 0.949
0.5 0.951 0.947 0.947 0.951
1.0 0.952 0.949 0.951 0.945
4
1.5 0.948 0.948 0.946 0.949
2.0 0.949 0.950 0.943 0.948
0.5 0.948 0.949 0.948 0.950
1.0 0.952 0.951 0.953 0.951
8
1.5 0.946 0.951 0.945 0.950
2.0 0.948 0.950 0.948 0.950
Table 4.6: SCP of one-sided (upper) SCIs for p = 5 treatments, the Dunnett contrast,
several numbers of endpoints, ratios γli = γ (for all l = 1, . . . , 4 and i = 1, . . . , k),
and equicorrelations; α = 0.05.
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4.5 Power Considerations
As in Section 3.5, the testing problem (4.1) is here again simplified to the case of
equal thresholds, θli = θ for all l = 1, . . . , q and i = 1, . . . , k. Let higher response
values indicate better treatment effects and τ ∗ denote the greatest irrelevant ratio to
the control mean which is to be detected. Define the set of indices I (τ ∗) = {(l, i) :
τli > τ
∗}. All ratios of contrasts with τli values greater than τ ∗ are relevant. In the
same manner as in Section 3.5, an (approximate) expression for the complete (or
all-pairs) power of the statistical problem (4.1) is given by
P
{
Tli > t
l
qk,1−α(ν, R˜)
∣∣∣∣ψli,Σ ∀(l, i) ∈ I(θ∗)} . (4.4)
An (approximate) expression for the minimal (or any-pair) power of the statistical
problem (4.1) is given by
P
{
Tli > t
l
qk,1−α(ν, R˜)
∣∣∣∣ψli,Σ for at least one (l, i) ∈ I(θ∗)} . (4.5)
The probability to reject for any contrast is defined as the global power. If one is
interested only in the global test decision for statistical problem (4.1), then this
definition is appropriate. An (approximate) expression for the global power of the
statistical problem (4.1) is given by
P
{
Tli > t
l
qk,1−α(ν, R˜)
∣∣∣∣ψli,Σ for at least one l = 1, . . . , q and i = 1, . . . , k} .
(4.6)
Because the data’s correlations are estimated, the quantiles tlqk,1−α(ν, R˜) in fact
are random variables because they depend on the sample values. Therefore, the
probabilities (4.4), (4.5) and (4.6) are only approximate ones. The power function
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(4.6) can be calculated from a non-central qk-variate t-distribution with ν degrees
of freedom and non-centrality parameter κ = (κ11, . . . , κli, . . . , κqk)′, where
κli =
∑p
h=1 (clh − θdlh)µhi√
σii
∑p
h=1 (clh − θdlh)2 /nh
=
(cl − θdl)′µ,i√
σii (cl − θdl)′M (cl − θdl)
.
Figure 4.1 (4.2) illustrates Equation (4.6) for three (five) treatments and the Dunnett
contrast depending on the ratio γq1 = µp1/µ11 (where q = p − 1). The remaining
ratios γli are fixed and equal. The relative thresholds against which the test is
performed are θli = 1 for all l = 1, . . . , q and all i = 1, . . . , k. Several equicorrelations
(rows) for two, four and eight endpoints (columns) are considered. The total sample
size is 60 (100). Three allocations are shown each. The solid line represents the
well-known optimal allocation for the Dunnett contrast, i.e., n1 =
√
p− 1nh (h =
2, . . . , p). Hence, the sample size for the control group is n1 = 24, 12, 6 (32, 16, 8), and
the sample sizes for the non-control groups are balanced. Although the correlations
of the endpoints are taken into account, their exact influence it is not clear from
Figures 4.1 and 4.2. Therefore, this problem is presented by Figure 4.3 (4.4). Again,
Equation (4.6) is illustrates for three (five) treatments with a similar background,
but now depending on the correlations of the endpoints. The ratio γq1 is set here
to 1.25. One-sided and two-sided tests (rows) for two, four and eight endpoints
(columns) are considered. The power indeed depends on the correlations. The
minimum is achieved for vanishing correlation and increases for increasing absolute
correlation values.
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Figure 4.1: Global power function of one-sided MCTs for p = 3 treatments, the
Dunnett contrast, several numbers of endpoints, ratios γq1, and equicorrelations;
α = 0.05.
102 CHAPTER 4. MCTS FOR MULTIPLE ENDPOINTS
Figure 4.2: Global power function of one-sided MCTs for p = 5 treatments, the
Dunnett contrast, several numbers of endpoints, ratios γq1, and equicorrelations;
α = 0.05.
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Figure 4.3: Global power function of MCTs for p = 3 treatments, the Dunnett
contrast, several numbers of endpoints, and equicorrelations; γq1 = 1.25, α = 0.05.
Figure 4.4: Global power function of MCTs for p = 5 treatments, the Dunnett
contrast, several numbers of endpoints, and equicorrelations; γq1 = 1.25, α = 0.05.
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The package multtest [Pollard et al., 2007] of the statistical software R [2008] pro-
vides resampling-based multiple hypothesis testing. Non-parametric bootstrap and
permutation tests are implemented. Tests based on t- and F -statistics are included.
The main application of this package is gene selection in microarray experiments.
The function MTP performs test procedures for multiple endpoints by single-step and
step-down minP and maxT methods to control the FWE (or other error rates).
Tests based on t-tests are restricted to comparisons of two groups, e.g. a treatment
and a control. A simulation study has been performed to compare this t-test-based
bootstrap approach (Boot.) with the new MCT method (Multiv.). The single-step
option method=‘‘ss.maxT’’ has been used for comparability. The parameter back-
ground is the same as in Section 4.3, but p = 2 (hence q = 1) with θ1i = 1 for all
i = 1, . . . , k. Figure 4.5 shows the results of the mentioned power comparison. The
rows are related to the different equicorrelations, the columns to the number of end-
points. Minimal and complete power coincide in this case, because the treatment
group differs only for the first endpoint. A higher power of the new multivariate
method is visible only for high correlations and high numbers of endpoints. Figure
4.6 shows the minimal power for the case that the mean of the treatment group was
changed simultaneously for all endpoints and by the same relative amount. Except
for the minimal equicorrelation ρmin, the bootstrap method is better with respect
to power than the new method. This difference becomes more pronounced with
increasing correlation and with increasing number of endpoints. Figure 4.7 shows
the complete power for the same background (simultaneously changing the mean
of the treatment group for all endpoints). The bootstrap method has slightly less
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power than the multivariate method, but this difference becomes negligible for high
correlations. In summary: The power behavior of the competitors is almost equal.
The gain in the minimal power for the bootstrap approach is insignificant in view
of the properties and flexibility of the new MCT method.
4.6 Heteroscedasticity
The same assumptions are made as in Section 4.2 except that there are possibly
different covariance matrices Σh = (σh,ii′)i,i′ for the treatments h = 1, . . . , p. In
practice, that means the treatments to cause different variances or correlations over
the endpoints, i.e.,
{Xhij : i = 1, . . . , k} ∼ ⊥Nk(µh,Σh) (h = 1, . . . , p, j = 1, . . . , nh).
Furthermore, let (nh − 1) ≥ k for all h = 1, . . . , p. The appropriate test statistics
are
Tli =
∑p
h=1 (clh − θlidlh) X¯hi√∑p
h=1 (clh − θlidlh)2 S2hi/nh
=
(cl − θlidl)′ X¯ ,i√
(cl − θlidl)′ Vˆ iM (cl − θlidl)
(l = 1, . . . , q, i = 1, . . . , k),
where Vˆ i is the estimator of V i with
V i =

σ1,ii 0
. . .
0 σp,ii
 and Vˆ i =

S21i 0
. . .
0 S2pi
 (i = 1, . . . , k),
respectively.
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Figure 4.5: Minimal and complete power function of one-sided MCTs for p = 2
treatments, the Dunnett contrast, several numbers of endpoints, and equicorrelations;
γq1 = 1, α = 0.05.
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Figure 4.6: Minimal power function of one-sided MCTs for p = 2 treatments, the
Dunnett contrast, several numbers of endpoints, and equicorrelations; γq1 = 1, α =
0.05.
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Figure 4.7: Complete power function of one-sided MCTs for p = 2 treatments,
the Dunnett contrast, several numbers of endpoints, and equicorrelations; γq1 = 1,
α = 0.05.
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We apply now the results of Chapter 3, thereby extending the PI procedure (which
is based on the method of Games and Howell [1976]) to the case of multiple end-
points. The degrees of freedom for the different contrasts and endpoints are related
to Equation (3.11), i.e.,
νli =
(∑p
h=1
(clh−θlidlh)2σh,ii
nh
)2
∑p
h=1
(clh−θlidlh)4σ2h,ii
n2h(nh−1)
(l = 1, . . . , q, i = 1, . . . , k).
Replacement of the unknown parameters σh,ii (h = 1, . . . , p, i = 1, . . . , k) with the
estimators S2hi yields1
νˆli =
(∑p
h=1
(clh−θlidlh)2S2hi
nh
)2
∑p
h=1
(clh−θlidlh)4S4hi
n2h(nh−1)
(l = 1, . . . , q, i = 1, . . . , k). (4.7)
These different degrees of freedom again lead to different, non-equidistant quantiles
for the test decisions. Therefore, this procedure is not a simultaneous test procedure
in the sense of Gabriel [1969]. However, because it is a UIT, Theorem 2.1.3 holds,
and it is coherent and consonant. The derivation of the correlation matrix can be
performed in analogy to the one given in Section 4.2. We have
Cov
(
p∑
h=1
(clh − θlidlh) X¯hi,
p∑
h=1
(cl′h − θl′i′dl′h) X¯hi′
)
=
p∑
h=1
(clh − θlidlh) (cl′h − θl′i′dl′h)Cov
(
X¯hi, X¯hi′
)
and
Cov(X¯hi, X¯hi′) =
1
nh
Cov(Xhi, Xhi′).
1The degrees of freedom in (4.7) must be greater than or equal to 2 for a well defined distribution.
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Now, we obtain
ρll′,ii′ = Corr
(
p∑
h=1
(clh − θlidlh) X¯hi,
p∑
h=1
(cl′h − θl′i′dl′h) X¯hi′
)
=
∑p
h=1 (clh − θlidlh) (cl′h − θl′i′dl′h) 1nhCov(Xhi, Xhi′)√
V ar
(∑p
h=1 (clh − θlidlh) X¯hi
)√
V ar
(∑p
h=1 (cl′h − θl′i′dl′h) X¯hi′
)
=
∑p
h=1 (clh − θlidlh) (cl′h − θl′i′dl′h) 1nhσh,ii′√∑p
h=1 (clh − θlidlh)2 V arX¯hi
√∑p
h=1 (cl′h − θl′i′dl′h)2 V arX¯hi′
and
ρll′,ii′ =
∑p
h=1 (clh − θlidlh) (cl′h − θl′i′dl′h) 1nhσh,ii′√∑p
h=1 (clh − θlidlh)2 1nhσh,ii
√∑p
h=1 (cl′h − θl′i′dl′h)2 1nhσh,i′i′
=
(cl − θlidl)′W ii′M (cl′ − θl′i′dl′)√
(cl − θlidl)′ V iM (cl − θlidl)
√
(cl′ − θl′i′dl′)′ V i′M (cl′ − θl′i′dl′)
(1 ≤ l, l′ ≤ q, 1 ≤ i, i′ ≤ k),
where
W ii′ =

σ1,ii′ 0
. . .
0 σp,ii′
 (1 ≤ i, i
′ ≤ k).
The behavior of this procedure is now predictable, in principle. Both the MCT
for multiple endpoints described in this chapter and the MCT for heteroscedastic
data described in Chapter 3 are the basis. Both have been checked by simulations
and have been shown to have good properties. Nevertheless, they are approximate
procedures, and their combination is approximate a fortiori. Estimators of variances
and correlations are used, and the use of the multivariate t-distribution itself is an
approximate approach. For that reason, a short simulation study is advisable here
too, with the same background as in Section 4.3 but with some differences: The
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correlations of the data have no influence on the FWE according to Section 4.3, thus
random correlations are sufficient for that purpose. It is known from Chapter 3 that a
setting, combining the smallest sample size and the highest standard deviation is the
most critical one because it leads to a liberal behavior for a procedure that wrongly
assumes homogeneity. Hence, a similar setting has been chosen with sample size 20
for each endpoint of each treatment, except for the last treatment with sample size
10. The standard deviations are 0.25µ1 for the last treatment, 0.1µ1 for the others.
Additionally, not only the procedure described (referred to as PI) is considered here
but also again a Bonferroni-adjusted version (referred to as BON) and a procedure
which assumes homoscedasticity (referred to as HOM). A conservative variant of
PI is also appended here which takes the minimum of the degrees of freedom (4.7)
over the endpoints (referred to as MIN). Hence, not qk different degrees of freedom
are used for MIN, but q. Table 4.7 (4.8) shows results of the first (second) study
with three (five) treatments. As expected, HOM is liberal (0.131 – 0.320), BON is
conservative (0.028 – 0.052), where increasing numbers of treatments and endpoints
intensify these effects. PI varies around the nominal level of 0.05 with a slight
tendency to liberalism. This is obviously caused by the mentioned high degree
of approximation for that procedure. A dependence on the number of treatments
and endpoints is not observed. The MIN procedure is an alternative choice with a
realized level between BON and PI. It is less liberal than PI but can also be slightly
conservative. The ranges here are 0.042 and 0.055, while PI has 0.047 and 0.063.
Despite the small variations around the nominal α-level, the adjusted version of
the test behaves predictable. Hence, the behavior concerning the strong control of
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MCT Endpoints HOM BON PI MIN
2 0.131 0.049 0.055 0.053
Dunnett 4 0.179 0.052 0.059 0.053
8 0.227 0.048 0.055 0.049
2 0.137 0.035 0.047 0.046
Williams 4 0.184 0.039 0.053 0.048
8 0.244 0.036 0.055 0.042
Table 4.7: FWE of one-sided MCTs for p = 3 treatments, several contrasts, proce-
dures and numbers of endpoints; α = 0.05.
MCT Endpoints HOM BON PI MIN
2 0.138 0.039 0.049 0.048
Dunnett 4 0.190 0.041 0.053 0.048
8 0.275 0.048 0.063 0.051
2 0.169 0.031 0.056 0.055
Williams 4 0.227 0.028 0.053 0.049
8 0.320 0.034 0.061 0.051
Table 4.8: FWE of one-sided MCTs for p = 5 treatments, several contrasts, proce-
dures and numbers of endpoints; α = 0.05.
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the FWE, the SCIs and the power are also obvious from the previous sections and
chapter. For that reason, we do not consider them here explicitly.
4.7 Example
Schulte et al. [2002] have taken measurements of 16 liver enzymes for an inter-
laboratory immunotoxicity study in nine centers. Ten animals per sex have been
randomized to a control (0) and three dose groups each. For simplicity, three en-
zymes are considered here from only the females and from the first center (see Table
4.9).
The aim is to show for which doses and for which enzymes the specified substance
leads to significantly smaller values than the control. The control group is denoted
Dose ASAT ALAT ALP
0 86.944 (11.880) 57.0752 (10.719) 461.496 (46.349)
1 80.080 ( 8.784) 49.2674 ( 4.922) 391.304 (47.909)
2 81.536 (18.957) 51.9610 (10.764) 308.976 (43.728)
3 81.536 ( 8.133) 46.3008 ( 8.349) 281.260 (29.945)
Table 4.9: Sample means (and standard deviations) per dose and enzyme of the data
set of Schulte et al. [2002].
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by h = 0 and the doses by h = 1, 2, 3. Application of the contrast matrices
C =

c′1
c′2
c′3
 =

0 1 0 0
0 0 1 0
0 0 0 1
 ,
D =

d′1
d′2
d′3
 =

1 0 0 0
1 0 0 0
1 0 0 0

leads to the ratios of contrasts
γli =
µli
µ0i
(l = 1, 2, 3, i = 1, 2, 3).
The hypotheses to be tested are given by
H0,li : γli ≥ θ (l = 1, 2, 3, i = 1, 2, 3)
with θ = 1. We assume heterogeneous covariance matrices over the doses. Table
4.10 shows the upper limits for the related approximate (1 − α)100% SCIs for the
ratios to the control means. The values in parentheses are the estimated ratios. For
ALP, all doses show significantly smaller values than those of the control.
Dose ASAT ALAT ALP
1 1.075 (0.921) 1.056 (0.863) 0.971 (0.848)
2 1.177 (0.938) 1.159 (0.910) 0.776 (0.670)
3 1.091 (0.938) 1.019 (0.811) 0.691 (0.609)
Table 4.10: Upper confidence limits (and estimates) per dose and enzyme for the
liver data of Schulte et al. [2002].
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As in Section 3.6.1, the testing problem has been formulated as a proof of hazard be-
cause toxicity should be pointed out. The conclusion of safety of the non-significant
doses is not warranted. A proof of safety would be the proper choice to answer
the question as to which doses do not cause a critical decrease as compared to the
control. We do not consider that in detail here, however.
Chapter 5
Discussion
The problem of heteroscedasticity in MCTs is that it is impossible (up to now) to
derive a joint distribution for the test statistics (T ∗1 , . . . , T ∗q )′. The basic idea of
Games and Howell [1976] was to compare each test statistic with “its own” specific
quantile coming from a comparison-specific multivariate t-distribution with degrees
of freedom according to Satterthwaite [1946]. This method has been extended to
the general case of MCTs for both differences and ratios of means (GH). A further
step has been to plug the estimates S2h (h = 1, . . . , p) into the correlation matrix
instead of the unknown σ2h (PI). Both comparison-specific degrees of freedom and
a correlation matrix depending on sample variances are necessary to maintain the
FWE over all situations. Approaches with a single degree of freedom (like HTL)
may notedly fail the more the variances differ. Only in the homoscedastic situation,
the methods considered, including the test for homoscedastic data (HOM), realize
the same (and correct) α-level. In this case, PI has a power that is only slightly
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smaller than that of HOM. Keeping in mind that it is hard to decide in practice
whether the data are homoscedastic or not, the PI procedure can therefore be rec-
ommended as a default. Also many functions of the statistical software R [2008]
assume heterogeneous variances for the data if no further information is specified by
the user. For example, see the command t.test(...). Moreover, calculations con-
cerning MCTs for heteroscedastic data are already available from R [2008], using the
commands simtest.ratioVH(...) and sci.ratioVH(...) of the package mratios
[Dilba et al., 2008, 2007]. This package provides tests and confidence intervals for
ratios of treatment means in the usual one-way layout.
Furthermore, the problem of many – possibly correlated – endpoints has been in-
vestigated. MCTs and related SCIs have been restricted to comparisons on a single
endpoint so far. This methodology was extended to the case of an arbitrary num-
ber of endpoints by deriving an approximate multivariate t-distribution. Ratios of
means have been considered for comparability of the different endpoints which may
have different scales. An approach for differences of means has not been focused ex-
plicitly, but it can easily be obtained based on this work. If variances or correlations
are assumed to differ for the different groups, the PI procedure for heterogeneous
variances of Section 3 can be applied. The procedures presented can be shown to
maintain the FWE. The version for heterogeneous covariances shows a slight liber-
alism, but it is in acceptable ranges. Test decisions (e.g., p-values) for all contrasts
and all endpoints are available as well as SCIs. For this reason, a fair power compar-
ison with existing methods is not feasible. A resampling-based competitor with the
same features exists only for the case of comparisons of only two groups (package
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multtest [Pollard et al., 2007] in R [2008]). Depending on which power is consid-
ered, the new method has about the same power properties or it is slightly worse.
This is compensated by a gain in flexibility.
A software realization in R [2008] regarding the methods described in this work
is available at http://www.r-project.org. The package SimComp [Hasler, 2008]
provides calculations concerning simultaneous tests and confidence intervals for both
difference- and ratio-based contrasts of normal means for data with possibly more
than one primary endpoint. The covariance matrices may be assumed to be equal
or possibly unequal for the different groups.
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